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ABSTRACT
Background
This thesis describes the psychological impact of an anal cancer screening
program on Human immunodeficiency virus (HIV) -infected men who have sex with
men (MSM). It also explores the effect of the personal characteristics psychological
flexibility (PF) and difficulty identifying and describing feelings (DIDF) on the mental
health of these men in the context of anal cancer screening. Anal cancer screening is a
relatively new public health initiative, as it is being realised that HIV-infected MSM are
at a high risk for this disease. The potential for cancer screening programs to create
uncertainty and distress has been highlighted by studies of other screening programs.
Very little research has focussed on the impact of anal cancer screening and the role of
PF and DIDF in this process. Three hypotheses were proposed:
1. The anal cancer screening process will decrease well-being, especially, in men who
receive higher risk grades of cytology and histology results.
2. The impact of adverse medical results will depend on how much DIDF and PF the
participant displays.
3. The level of DIDF and PF will determine the development of positive mental health
regardless of medical results.
Methodology
A prospective longitudinal survey of 291 men was conducted at three time
points over 14 weeks at a public HIV clinic in Sydney, Australia. Self-report
questionnaires measuring worry, distress, depression, anxiety, stress and health-related
quality of life (QOL) were collected. PF was assessed by the Acceptance and Action
Questionnaire II and DIDF by the Toronto Alexithymia Scale-20.
Results
Following initial screening, men who had a follow-up biopsy recommended
were significantly more worried about anal cancer, rated their anal health worse and
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were less optimistic about their future health than the control group who needed no
further medical investigation. Subsequently men receiving high grade histology results
remained worried about anal cancer. Getting initial bad results and then reassuring
results lead to higher optimism than getting an initial good result. After follow-up
testing, the reassured group became more optimistic about their health than either the
low threat or high threat group. There was no evidence that general anxiety, depression
or QOL was significantly affected by the screening process.
There was no evidence that levels of PF and DIDF impacted the level of worry
about cancer through the screening process. However, both DIDF and PF were reliable
predictors of mental health. When levels of baseline mental health were controlled,
greater DIDF predicted increases in depression, anxiety and stress, and decreases in
mental and physical QOL over the screening period. The link between PF and mental
health was entirely mediated by DIDF.
Conclusions
These results provide a better understanding of how anal cancer specific worry
increases throughout the screening process for some men and the role of PF and DIDF
to enhance mental health. Being chronically low in PF could lead to greater DIDF and
thereby worse mental health. More research is needed to determine whether having
more PF promotes the ability to identify and differentiate the nuances of pleasant and
unpleasant emotions which enhance an individual’s mental health. Intentionally
enhancing men’s ability to identify and describe feelings or PF may assist them to better
manage a range of difficult life experiences such as health screenings and other
potentially threatening information. Recommendations are also made for appropriate
supports and implementation of clear communication prior to and during anal cancer
screening.
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CHAPTER ONE
OVERVIEW, AIMS AND CHAPTER SUMMARIES
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1.1 OVERVIEW
Anal cancer rates have been increasing in Australia over the last 30 years (Jin et al.,
2011). In the 1982-1987 time period the incidence rate of invasive anal cancer was
0.91/100,000 increasing to 1.35/100,000 in 2000-2005 (Jin, et al., 2011). The increase
was greater in men than women, and the incidence rate of squamous cell carcinomas in
men climbed from 0.48/100,000 to 0.88/100,000 in that time period (Jin, et al., 2011).
While anal cancer is rare in the general population in comparison to other cancer rates
for males, (e.g. in 2005 Lung 60.3/100,000 and Prostate cancer 168.5/100,000
(Australian Institute of Health & Welfare, 2005), there are high risk populations who
carry most of the disease burden. These groups are HIV- infected men who have sex
with men (MSM) who have rates between 42 and 137/100,000 (Darragh & Winkler,
2011) and MSM who have a 25% prevalence rate (Chin-Hong et al., 2008). Women
with previous human papillomavirus (HPV) genital disease are also at higher risk, one
study found 12% of women with cervical HPV disease also had anal disease (Santoso,
Long, Crigger, Wan, & Haefner, 2010).
Anal cancer is related to high risk types of HPV infection, similar to cervical
cancer. Cervical cancer screening has been successful in reducing rates of cervical
cancer, and similarly it is hoped that anal cancer screening will result in reduced rates of
anal cancer. A number of research trials have been initiated to assess the impact of anal
cancer screening, particularly in high risk groups (Chin-Hong, et al., 2008; Nathan,
Hickey, Mayuranathan, Vowler, & Singh, 2008; Tinmouth et al., 2011). The medical
debate continues about the similarities of anal and cervical disease and more thorough
research is being called for prior to offering screening on a wider scale (Jin, et al.,
2011). Meanwhile anal cancer screening is being recognised as an important health
prevention tool in high risk populations with at least one set of guidelines
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recommending screening for HIV-infected individuals (New York State Department of
Public Health AIDS Institute, 2007).
Breast, prostate and cervical cancer screening programs have a negative impact
on psychological well-being, such as increased worry, anxiety and use of medical
interventions and decreased quality of life (Brett, Bankhead, Henderson, Watson, &
Austoker, 2005; Gray et al., 2006; McNaughton-Collins et al., 2004). There are
numerous medical studies focussed on anal cancer screening, but limited published data
on the psychological impact of that screening. A Canadian study by Tinmouth and
colleagues (2011) is the only other published study. The medical process used by
Tinmouth et al. (2011) was determined by the demands of the research context with
both the initial and follow-up screening procedures at the same time for each
participant. This is unlikely to be the method used by screening programs outside of a
research program due to cost and resource demands. Thus, there is a need to better
understand the effects of anal cancer screening under more naturalistic circumstances.
Specifically, whether anal cancer screening via a two stage process has similar
psychological impacts to other types of cancer screening programs. Most cancer
screening programs use a two stage process of initial screening and follow-up testing for
those whose results indicate the need for further investigation (Brett, et al., 2005;
Fowler et al., 2006).
Even though cancer screening has the potential to decrease well-being, not every
individual is expected to be influenced in the same way. This variation could be related
to the individuals’ personal or family contact with cancer, familiarity with medical
testing processes, capacity to manage stress and uncertainty, and current mental health.
This study focuses on two individual characteristics, difficulty in identifying and
describing feelings (DIDF), which is a major component of alexithymia (Bagby, Parker,

Page | 3

& Taylor, 1994) and psychological flexibility (PF; Hayes, Luoma, Bond, Masuda, &
Lillis, 2006). PF is the ability to be in the present moment and to behave in ways that
are adaptable and will achieve a person’s values (Hayes, et al., 2006). Both PF and
DIDF are concerned with how a person relates to their emotions rather than being about
the emotions themselves. The medical process of cancer screening is likely to illicit a
variety of emotions and how each individual relates to these emotions may determine
their reactions and ability to cope. These characteristics are likely to be particularly
relevant to this population of HIV-infected men as alexithymia and lower PF are more
common in men (Karekla & Panayiotou, 2011; Mattila et al., 2008) and are linked to
health related outcomes (Kashdan & Rottenberg, 2010; Kauhanen, Kaplan, Cohen,
Julkunen, & Salonen, 1996; Saharinen et al., 2008).
Previous research has shown the benefit of PF and the ability to identify and
describe feelings. Increasing PF in chronic pain patients has been shown to increase
their well-being (Thompson & McCracken, 2011). Additionally, both DIDF and PF
have been found to explain differences in psychological functioning (Berrocal, Pennato,
& Bernini, 2009; Gloster, Klotsche, Chaker, Hummel, & Hoyer, 2011), physical wellbeing (McCracken & Zhao-O'Brien, 2010; Saharinen, et al., 2008) and quality of life
outcomes (Hayes, et al., 2006; Modestin, Furrer, & Malti, 2004).
There is an abundance of research on alexithymia and PF in the health
psychology field. However, there is little research which investigates their relationship
and interaction with mental health.
1.1.1 Aims and Hypotheses
The broad aim of this research was to investigate the psychological impact of anal
cancer screening and the influence of PF and DIDF on the men undergoing that process.
Three hypotheses were proposed:
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1.

The anal cancer screening process will decrease well-being, especially, in men
who receive higher risk grades of cytology and histology results.

2.

The impact of adverse medical results will depend on how much DIDF and PF the
participant displays; i.e., an adverse screening result will be more upsetting to men
who are poor at identifying and describing feelings and low in psychological
flexibility.

3.

The level of DIDF and PF will determine the development of positive mental
health regardless of medical results.
1.2 METHODS

1.2.1 Design and Procedures
A multi-wave longitudinal study of 291 HIV-infected MSM undergoing anal cytological
screening was conducted at St Vincent’s Hospital in Sydney, Australia. Recruitment
commenced in October 2008 with the final participants completing in April 2010. The
study was approved by the human research ethics committee of the hospital (SVH
HREC Ref: 08/SVH/60) and written informed consent was obtained from all
participants. Any HIV-infected MSM who attended the HIV clinic during the study
period were eligible. Exclusion criteria included a significant bleeding disorder, anal
pathology likely to render an anal swab significantly uncomfortable, and being unable
or unwilling to give informed consent.
The study consisted of three stages over approximately 14 weeks for each
participant as illustrated in Figure 1.1 (Appendix One contains a more comprehensive
participant flow chart). The medical aspects of the screening study began with a sexual
health research nurse conducting a detailed history of sexual and anal health, and giving
instructions regarding the self-collection of swabs for anal cytology and anal bacterial
sexually transmitted infections. The cytology results were delivered based on
Page | 5

participant’s preferences (phone, mail, e-mail or in person). Participants whose swab
yielded cytology results that were technically unsatisfactory were invited to have a
second swab. Participants with negative or Low Grade Squamous Intraepithelial Lesion
(LSIL) cytology results formed the control group. Further investigation by high
resolution anoscopy (HRA) was offered to participants whose cytology results were;
High Grade Squamous Intraepithelial Lesion (HSIL), Atypical Squamous Cells-Cannot
exclude HSIL (ASC-H), or Atypical Squamous Cells - Unknown Significance (ASCUS). The HRA procedure is similar to colposcopy investigation of cervical cytology
abnormalities. Following the HRA procedure, histology results were given in person or
by mail and follow-up options discussed.
The psychological impact assessments occurred at the three stages of the medical
process. The measures included in each questionnaire pack are outlined in Table 1.1 and
are located in Appendix Two. The first questionnaire pack was given at the initial
interview, to be completed that day and mailed back. The second and third
questionnaire packs were mailed in the week following the date the participant received
their cytology and histology results (for those having an HRA). This occurred at
approximately two weeks and 12-14 weeks after baseline. Participants who were not
offered an HRA were sent the third questionnaire pack at a time matched interval of 12
weeks after baseline. The questionnaire packs consisted of a variety of well standardised
measures as outlined in Table 1.1 and took 20-30 minutes to complete. Identical
questionnaire packs were used, except questionnaire pack three for the HRA group,
which contained questions about their HRA experience (Appendix Two). Reminder
letters were sent a week after the initial posting.
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Eligible n=471

Recruitment

Consent,
interview, swab
& blood test
n=291
Questionnaire
One n=271

Baseline

Cytology Result
Negative & LSIL
Questionnaire
Two n=149

Cytology Results
ASCUS, ASC-H
& HSIL
Questionnaire
Two n=71

Time 2
2 weeks later

No Medical
Follow-up

HRA Procedure
n=66

8-10 weeks later

Questionnaire
Three n=113

Histology Result
No Biopsy,
Negative, LSIL,
Wart Virus &
Other
Questionnaire
Three n=22

Histology Result
HGAIN
Questionnaire
Three n=28

Time 3
2 weeks later

Figure 1.1 Participant Flow Chart
N= completed questionnaires; LSIL= Low Grade Squamous Intraepithelial Lesion;
HSIL = High Grade Squamous Intraepithelial Lesion; ASC-US = Atypical Squamous
Cells: Unknown Significance; ASC-H = Atypical Squamous Cells: Cannot exclude
HSIL; HRA= High Resolution Anoscopy; HGAIN = High Grade Anal Intraepithelial
Neoplasia

Page | 7

1.2.2 Participants
Ninety nine percent (287/291) of the medical study sample participated in the
psychological impact study as outlined in Figure 1.1. The individual questionnaire
response rates were 94% (271/287) at baseline, 84% (220/263) at time two after
cytology, and 79% (50/63) at time three for the group receiving histology results, and
82% (113/138) for the control group. Some participants had an HRA (n=11) off
protocol for investigation of warts, some declined an HRA (n=5) and others withdrew
from the study (n=5).
1.2.3 Measures
Test Specific Psychological Questionnaires (TSPQ)
The Anal Screening Questionnaire (ASQ) was created by modifying the Cervical
Screening Questionnaire (CSQ; Wardle, Pernet, & Stephens, 1995). Questions cover
general and anal health, body image, sexual interest and optimism about future health,
with items rated on a 4-point Likert scale. The worry questions from the CSQ were
omitted and the adapted prostate cancer worry items from McNaughton-Collins et al.
(2004) were used. This measure assesses worry about cancer, dying soon, and
reassurance from testing.
The Distress Thermometer is a single item utilising a Likert type scale from 0=No
distress to 10=Extreme Distress (Jacobsen et al., 2005). It measures subjective distress
in relation to specific aspects of the screening process such as, “waiting for the swab
results” or “since the HRA results”.
Generalised Psychological Questionnaires (GPQ)
Medical Outcomes Study Short Form Health Survey (SF-12) is a measure of
health related quality of life (QOL), with two summary scales of physical (PCS) and
mental (MCS) well-being.
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The Depression Anxiety Stress Scale (DASS-21; Lovibond & Lovibond, 1995)
measures depression, anxiety and stress. Items such as, “I felt scared without any good
reason”, are rated on a 4-point Likert scale.
Proposed Mediator Questionnaires
Difficulty identifying and describing feelings (DIDF) were measured by subscales
of the Toronto Alexithymia Scale-20 (TAS-20; Bagby, et al., 1994). The scale included
items such as: “When I am upset, I don’t know if I am sad, frightened, or angry” and “It
is difficult for me to find the right words for my feelings”. Higher scores indicate less
ability to identify emotions. For the purpose of the present study, one scale was formed
by combining the 12 items rating difficulty identifying and describing feelings.
Psychological Flexibility (PF) was measured using The Acceptance and Action
Questionnaire II (AAQ-II; Bond et al., 2011). The AAQ-II measures the tendency to
control thoughts and feelings and the ability to act in the presence of difficult thoughts
or feelings. It is the most well-established measure of psychological flexibility,
measuring the totality of the above processes (Gloster, et al., 2011; Luoma, Drake,
Kohlenberg, & Hayes, 2011). Each item is rated on a 7-point Likert scale (e.g., ‘‘I
worry about not being able to control my worries and feelings’’ and ‘‘My painful
memories prevent me from having a fulfilling life”). Higher scores indicate higher PF.

Table 1.1 Measures Administered at each Time Point
Measure
Distress Thermometer
Anal Screening Questionnaire (ASQ)
Depression, Anxiety Stress Scale 21 (DASS-21)
Medical Outcomes Short Form 12 (SF-12)
Toronto Alexithymia Scale 20 (TAS-20)
Acceptance and Action Questionnaire II (AAQ-II)

Baseline

Time 2

Time 3

X
X
X
X
X
X

X
X
X
X

X
X
X
X
X
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1.3 SUMMARY OF CHAPTERS
This thesis comprises four other chapters in addition to this chapter overview.
1.3.1 Chapter Two
Chapter two is a systematic review of the literature related to the psychosocial
impact of anal cancer screening. This review (Landstra, Ciarrochi, & Deane, 2012) was
published in a special issue of Sexual Health focussed on anal cancer. This chapter
provides a description of typical screening processes, previous research investigating
the hypothetical and potential psychosocial impact of anal cancer screening. There were
two studies directly related to men undergoing screening, our study and one conducted
in Canada (Tinmouth, et al., 2011). Other studies focussed on knowledge of, willingness
or barriers to screening, sexuality and evaluation of screening procedures and factors
related to follow-up treatment and re-screening. The review suggested that screening
has no significant effect on general mental health but may increase cancer-specific
worry. Having worse anal or HIV symptoms, being younger, higher baseline distress or
worse histology results were related to greater worry.
1.3.2 Chapter Three
Chapter three examines the psychological impact of anal cancer screening as
published in Psycho-oncology (Landstra, Ciarrochi, Deane, Botes, & Hillman, 2012).
The main findings were that men who were recommended to have further investigation
by HRA showed differences on the test specific psychological questionnaires. They
were more worried, rated their anal health worse and were not as optimistic about their
future health. Furthermore those with high grade histology results remained worried.
Getting initial bad results and then reassuring results lead to higher optimism than
getting an initial good result. After follow-up testing, the reassured group became more
optimistic about their health than either the low threat or high threat group. We found no
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differences between the groups at any time point on the more generalised psychological
questionnaires measuring depression, anxiety, stress and quality of life.
1.3.3 Chapter Four
Chapter four outlines the relationship between PF, DIDF and mental health as
published in an article in British Journal of Health Psychology (Landstra, Ciarrochi,
Deane, & Hillman, 2013). DIDF and PF are both defined and research on their relations
with mental health and well-being is briefly reviewed. Both DIDF and PF were reliable
predictors of mental health. Three different models were tested to clarify the nature of
the relationships between DIDF, PF and mental health variables, The “Situation effect
model”, “Interaction model”, and “Resilience model”. Each model is specified in this
chapter. It was found that when levels of baseline mental health were controlled, higher
DIDF predicted increases in Time 2 depression, anxiety and stress, and decreases in
mental and physical QOL. The link between PF and mental health was mediated by
DIDF. Being chronically low in PF could lead to diminished emotion identification and
thereby worse mental health. Having more PF appears to promote the ability to identify
and differentiate the nuances of pleasant and unpleasant emotions which enhances an
individual’s mental health.
1.3.4 Chapter Five
Chapter five provides a summary of the conclusions, limitations of the research
and suggestions for future research directions.
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CHAPTER TWO

PSYCHOSOCIAL ASPECTS OF ANAL CANCER SCREENING:
A REVIEW AND RECOMMENDATIONS 1

1

This chapter is based substantially on the article Landstra, J. M. B., Ciarrochi, J., &

Deane, F. P. (2012). Psychosocial aspects of anal cancer screening: a review and
recommendations. Sexual Health, 9(6), 620-627. doi:
http://dx.doi.org/10.1071/SH11169
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2.1 ABSTRACT
Cancer screening programs have the potential to decrease psychosocial well-being. This
review investigates the evidence for anal cancer screening having an impact on
psychosocial functioning and outlines considerations for supporting participants. The
review suggested that screening has no significant effect on general mental health but
may increase cancer-specific worry. Having worse anal or HIV symptoms, being
younger, higher baseline distress or worse histology results were predictive of greater
worry. The findings suggest the need to increase education campaigns particularly
targeting those with HIV infection and men who have sex with men. There is a need to
develop a consensus on how to measure the psychosocial impact of screening and
stepped care approaches for responding to resulting distress.
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2.2 INTRODUCTION
Early detection screening programs are recommended for a variety of cancer
types. While there are well established population screening programs for other
cancers, anal cancer has not been recognised as a high priority for screening until the
last 5 to10 years (Herat, Whitfeld, & Hillman, 2007; Institute, 2007; Palefsky, 2007).
High rates of human papillomavirus (HPV) infection and anal cancer in HIV-infected
individuals and men who have sex with men (MSM) have led to a growing concern that
screening, prevention and early intervention efforts need to be implemented, similar to
other cancers (Darragh & Winkler, 2011). Baseline and annual follow-up anal
cytological screening is recommended for HIV-infected individuals in the New York
State AIDS Institute guidelines (2007). The need for screening programs has been
recognized with research studies being conducted in North America (Chin-Hong, et al.,
2008; Tinmouth, et al., 2011), Europe (Nathan, et al., 2008) and Australia (Botes et al.,
2011).
Progression and regression rates from HPV infection to anal cancer are
unknown, but the screening process is similar to the highly effective cervical cancer
model (Darragh & Winkler, 2011). While there is no universally accepted anal cancer
screening or treatment protocol, typically, the screening process involves two stages. A
swab is taken and sent for cytological analysis and if further investigation is warranted
from non negative cytology results, a high resolution anoscopy (HRA; similar to
colposcopy) is conducted to determine the extent of disease via biopsy and histology
results. The HRA process is potentially uncomfortable and painful. Additionally it is
during the waiting periods for both sets of results and for the HRA procedure that
patients may experience increased distress about the potential for bad news. The
severity of result may have an effect on the psychosocial response. Specifically,
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different results are likely to convey different levels of perceived risk of disease. For
example, the distinction between cancer and pre-cancer cytological and histological
results can be difficult for patients to understand. In a related area, cervical screening
participants found it, “difficult to understand cell changes as anything other than a lifethreatening illness” (Hounsgaard, Petersen, & Pedersen, 2007). Levels of education,
personal experience with cancer (self or others) and psychological status are all possible
moderators of the psychosocial response to screening. Both researchers and clinicians’
highlight the need to understand the potential psychosocial impact of screening
programs, particularly in response to uncertainty associated with screening, procedures
and results (Barratt et al., 2002; McCaffery & Barratt, 2004; McNaughton-Collins,
Fowler, et al., 2004; Shaw, Abrams, & Marteau, 1999; Stewart-Brown & Farmer,
1997).
2.2.1 Potential Psychosocial Impacts in Anal Cancer Screening
The psychosocial impact of anal cancer screening has not been widely investigated in
comparison to other forms of cancer. There are numerous studies and systematic
reviews examining the psychological effects of cervical (Szarewski, 2011), prostate
(McNaughton-Collins, Walker-Corkery, & Barry, 2004) and breast (Brett, et al., 2005)
cancer screening programs and these provide valuable insights into the potential
psychosocial effects of anal cancer screening.
The anal cancer screening process is similar to both prostate and cervical cancer
screening on several dimensions. For example, they are associated with private parts of
the body and related to sexuality. The screening process has two stages and is very
similar to cervical and slightly different to prostate, with a blood test for prostate
specific antigen (PSA) followed by transrectal ultrasound-guided and random biopsy.
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Increased anxiety, worry about cancer and lower sexual well-being has been
found with all grades of cervical cytology results (French, Maissi, & Marteau, 2004;
Gray, et al., 2006; Wardle, et al., 1995). Rates of return for repeat testing are lower in
those who are most anxious (French, et al., 2004). Men with normal PSA results were
less worried than men with benign biopsies even after 12 months. Those with benign
biopsies had sought more medical follow-up, talked more to their partners and sought
information from the internet (Fowler, et al., 2006; McNaughton-Collins, Fowler, et al.,
2004). It may be that repeat testing, biopsy and concern about false negative biopsies
contributed to the ongoing anxiety found, particularly as random biopsy is likely to miss
10% of men with active disease (Fowler, et al., 2006). While HRA is more targeted than
the prostate biopsy process there may be false negative rates in that process as well.
Other factors that have impacted psychosocial responses are having symptoms
prior to testing; for example men with urinary symptoms (Brindle et al., 2006) or higher
anxiety at baseline (Essink-Bot et al., 1998; Fowler, et al., 2006). Having more or less
knowledge about the screening and disease are also potential factors. Men who had
multiple PSA testing points had increased anxiety at the second and subsequent tests.
This may be due to awareness of cancer being raised by the initial PSA result and
increasing with each re-test (Carlsson, Aus, Wessman, & Hugosson, 2007). In contrast,
having repeated biopsies did not increase anxiety (Carlsson, et al., 2007) and although
speculative, it is possible that repeated biopsy was viewed as a more thorough test and
increased reassurance. Being given cervical HPV results increased anxiety (Szarewski,
2011), in part due to poor understanding and confusion about HPV infection,
particularly the difference between genital warts and high-risk HPV. When women
sought information, their anxiety diminished over time (Szarewski, 2011). Knowing that
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HPV can clear on its own and that it would not cause genital warts also reduced anxiety
(McCaffery, Waller, Nazroo, & Wardle, 2006).
Test specific psychological questionnaires (TSPQ) whether it be cervical or
prostate compared to generalised psychological questionnaires (GPQ) appear to be
associated with greater sensitivity to psychosocial responses to screening (McNaughtonCollins, Fowler, et al., 2004; Pickles, Ruether, Weir, Carlson, & Jakulj, 2007) and may
explain conflicting results between different studies. A number of studies have found
that PSA and biopsy results did not increase anxiety, depression or health related quality
of life (QOL) using GPQ (Brindle, et al., 2006; Carlsson, et al., 2007; Essink-Bot, et al.,
1998). It may be important for future studies to utilize TSPQ. There are psychosocial
impacts from cervical and prostate screening processes and the full range of medical
results. Screening programs can improve psychosocial responses by utilising better
patient information.
2.2.2 Aims
Screening programs have the potential to decrease psychosocial well-being and increase
avoidance of health testing. There have not been many direct studies in the anal cancer
field, so this systematic review will also integrate findings from other relevant cancer
screening areas. The aim is to identify the likely psychosocial effects of anal cancer
screening and then suggest how future screening programs could prevent or minimise
any negative impacts.
2.3 METHOD
2.3.1 Search Strategy
A search of four electronic databases using standard research procedures was conducted
in October 2011. The databases were Medline, PsychInfo, Cumulative Index of Nursing
and Allied Health Literature (CINAHL) and Web of Science. Search terms were entered
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with combined sets of terms relating to anal cancer, screening and psychosocial impact;
(anal) and (cytol* or screen*) and (psyc* or anxi* or worry). These four searches
identified 200 articles, 7 were unique and directly relevant to the review. It was not
possible to combine the data from these studies in order to conduct a meta-analysis due
to the highly variable measures and methods used.
2.3.2 Inclusion and Exclusion Criteria
Exclusion criteria were minimal, given the scarcity of publications on this topic. All
theoretical, descriptive or empirical studies on psychosocial characteristics of anal
cancer screening were included. Titles and abstracts were reviewed for the following
inclusion criteria:


Presented original research on psychosocial aspects of cancer screening



Screening was for anal cancer



Published in English

Articles were further excluded if they described cost effectiveness, surveyed health care
workers only, focused solely on patients diagnosed with cancer or the effects of cancer
treatment.
In order to assess one aspect of study quality and to begin describing the diverse
psychosocial domains investigated, those studies that used psychological measures with
some previously assessed reliability and validity were identified. Measures assessed in
other cancer screening contexts (e.g., cervical) were considered to have some
established reliability and validity. Table 2.1 summarises the seven studies.
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Table 2.1 Summary of Anal Cancer Screening Studies
Author, published,
country (study yr)

Participants (response
rate)
demographics

Design, methods & measures

Main results

Knowledge, Attitudes & Willingness to have Screening (no screening undertaken)
Pitts et al., 2007,

N=384

Cross sectional; paper questionnaire at a Gay Overall low rates of knowledge and

Australia (2005)

Previous screen 14%

community event.

previous anal screening. Primary care

Mean age 37yrs (16–67) Assessed health service use, knowledge,

physicians were main sources of sexual

HIV+ 6%

health check up; education needs to be

attitudes, and beliefs*

Relationship 47%

targeted at this group.

D’Souza et al., 2008,

N=1917

Longitudinal; 6, 12, 18 month reviews (visit

Overall low rates of previous anal

USA (2005-2006)

Previous screen 11%

43-45 in Multicenter AIDS Cohort Study);

screening, concern and intention to seek

Mean age 48 yrs

interviewer-administered and audio

anal screening.

HIV+ 47%

computer-assisted self interview.

Higher rates in HIV+ and in locations

Caucasian 63%

Anal Pap history, concern about anal cancer,

where perceived availability of screening

intention to seek screening, perceived

was greater.

screening availability

MSM rely on primary care physicians for

Men’s Attitude Survey*

anal health care, training and information
needs to be targeted to this group.
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Author, published,
country (study yr)

Participants (response
rate)
demographics

Design, methods & measures

Main results

Truesdale et al.,

N=195 (50 LTF, 49

Cross sectional; MSM previously diagnosed

Predictors of screening follow-up include

2010, USA (2007-

LCB, 96 RF)

with LSIL or HSIL anal dysplasia; RF &

a subjectively upsetting experience during

2008)

Previous screen 100%

LCB paper questionnaire in clinic LTF via

the initial HPV diagnosis, physical

HSIL^ 64%

telephone.

symptoms driving the initial visit to the

Mean age 43 yrs

Factors impacting return to screening;

physician and a diagnosis of HSIL.

HIV+ 49%

Subjective emotional experience following

Caucasian 78%

the initial HPV-related anal

Insurance 92%

dysplasia diagnosis, Knowledge of Anal Pap

Relationship 47%

& HPV* (adapted from Pitts 2007)

Reed et al., 2010,

N=306

Cross sectional; online survey of gay or

Overall low testing history and knowledge

USA (2009)

Previous screen 14%

bisexual members of Knowledge Networks

of anal screening.

Mean age 46 yrs (18-59)

US household panel.

HIV+ were more likely to have been

HIV+ 17%

Education presented before questions on

screened, aware of and concerned about

Gay 77%

anal cancer knowledge and concern, anal

anal cancer.

Caucasian 81%

pap test history, barriers and guidelines;

Willingness to pay for screening was

Insurance 86%

willingness to participate if test was free or

higher in those more worried about anal

Relationship 48%

$150

cancer.

Author, published,
country (study yr)

Participants (response
rate)
demographics

Design, methods & measures

Main results

( http://www.unc.edu/;ntbrewer/hpv.htm.)

Cost and lack of education were
significant barriers and need to be targeted
in the MSM and HIV+ population.

Evaluation of Screening Procedure
Botes et al., 2010,

N= 291 (RR 90%)

Cross sectional; evaluation of self collected

53% rated swab easy to collect and 81% as

Australia (2008-

Mean age 50yrs (26-75)

anal swab for screening. Ease of self

a highly acceptable method. This provides

2009)

HIV+ 100%

collection, acceptability, pain and bleeding

home collection options to improve cost
and privacy.

Psychosocial Impact of Screening Studies
Tinmouth et al.,

N=104 (RR 67%)

Prospective; paper or online questionnaires

Overall no adverse psychological impact

2011, Canada

AIN 2/3^ 14%

at 4 time points over 6 months (1 wk pre-

(anxiety & depression).

Mean age 44 yrs (41-50)

screen, 1 wk post-screen, 1 wk post-results,

Characteristics associated with greater

HIV+ 100%

1 wk pre- 6 mth follow-up) with participants

impact were: having higher baseline

of an anal cancer screening study.

distress, being younger & having more

Impact of Events Scale*

HIV-related symptoms.

Illness Intrusiveness Ratings Scale*

Support could be targeted to these

Psychological Consequences Questionnaire*

individuals with support groups or access
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Author, published,
country (study yr)

Participants (response
rate)
demographics

Design, methods & measures

Main results

Hospital Anxiety and Depression Scale*

to psychologists.

HIV Symptom Index*
Knowledge items
Landstra et al., 2012,

N=163 (RR 60%)

Prospective; paper questionnaire at 3 time

Overall no adverse psychological impact

Australia (2008-

HGAIN^ 17%

points over 3 months (at screening, 1wk post

(anxiety, depression, stress, QOL).

2010)

Mean age 52 yrs (28-73)

swab result and 1wk post HRA result) with

Cancer worry, anal health and optimism

HIV+ 100%

participants of an anal cancer screening

for future health ratings were impacted by

Relationship 49%

study.

the process, those requested to return for

Anal Screening Questionnaire*

HRA were more impacted and those who

Cancer Worry Scale*

had HGAIN histology results, remained

Distress Thermometer*

more worried.

MOS SF-12*
Depression Anxiety Stress Scale*
* Validated questionnaires; ^ HSIL, AIN & HGAIN are interchangeable terms for precancerous anal lesions; LSIL= Low Grade Squamous
Intraepithelial Lesion; HSIL= High Grade Squamous Intraepithelial Lesion; AIN 2/3 & HGAIN= High Grade Anal Intraepithelial Neoplasia;
RR=Response rate; LTF= Lost to follow-up; LCB= Lost came back; RF= regular follow-up; HPV= Human Papillomavirus; FT work= Full time
work; MSM= men who have sex with men; MOS SF-12= Medical Outcomes Study Short Form 12; QOL= Quality of Life

2.4 RESULTS
2.4.1 Measures of Psychosocial Functioning
The articles reviewed used a combination of validated and non-validated self-report
psychological measures which are listed in Table 2.1. The validated measures are
indicated in Table 1, they can be categorized into GPQ’s; for example, Hospital Anxiety
and Depression Scale and TSPQ’s such as, Psychological Consequences Questionnaire
positive scale, developed for impact of mammography screening on physical, social and
emotional domains. The non-validated measures were unique to each study and were
related to knowledge of HPV, anal cancer and anal pap tests; attitudes or beliefs;
willingness to seek or return to screening and evaluating screening procedures. All
measures which were readily available are in Appendix Five.
2.4.2 Knowledge, Attitudes & Willingness to Have Screening
Knowledge
The majority of studies had a knowledge assessment component. The first published
study on knowledge was in 2007 by Pitts et al. (Pitts, Fox, Willis, & Anderson, 2007),
who found no single item was answered correctly by more than half of the sample and
awareness of risk factors was poor. For example respondents had low awareness of risk
factors such as HPV, smoking and being a receptive sexual partner. While 62% had
received a sexual health screen in the past 12 months this was not associated with better
knowledge. Significantly higher knowledge was found in those who had higher
education (Pitts, et al., 2007), had ever had an anal pap screen (D'Souza et al., 2008;
Reed, Reiter, Smith, Palefsky, & Brewer, 2010) and among those undergoing regular
follow-up screening compared to patients lost to follow-up (LTF; Truesdale &
Goldstone, 2010). Amongst participants who had higher levels of knowledge or
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awareness of screening availability, there was greater willingness to have screening
(D'Souza, et al., 2008; Reed, et al., 2010).
Willingness
Three studies (D'Souza, et al., 2008; Reed, et al., 2010; Truesdale & Goldstone, 2010)
investigated factors related to intentions or willingness to participate in screening. Being
HIV-infected was related to being more willing to be screened (D'Souza, et al., 2008;
Reed, et al., 2010). Men indicated they were more willing to have screening that would
be free (83%) than if they incurred out of pocket costs of $150 (31%) (Reed, et al.,
2010). Those with household incomes over $60,000 were also more willing to be
screened than those earning less (Reed, et al., 2010). Truesdale and Goldstone
(2010) investigated factors related to men who have sex with men (MSM) with both low
and high grade squamous intraepithelial lesions (LSIL & HSIL) returning to screening
after 1 year. It was found that having more sexual partners led to greater rates of return,
with each additional partner increasing likelihood of return by 8%. Return to screening
was related to being contacted to take part in the study, leading to 7% of LTF having
further screening and 18% of the LTF participants returning for screening. Twelve
percent of MSM indicated that the anal pap smear was “too painful to make it
worthwhile” (Truesdale & Goldstone, 2010).
Worry
A variety of concerns or worries were related to knowledge and willingness to have
screening. Participants who described learning they had HPV as “upsetting” were 3
times more likely to have regular follow-up than be lost to follow-up (LTF) (Truesdale
& Goldstone, 2010). Furthermore, when treatment was prescribed at diagnosis
participants were 2 times more likely to be regular in follow-up testing than LTF
(Truesdale & Goldstone, 2010). Having greater worry about or higher perceived
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likelihood of getting anal cancer was related to being more willing to have screening.
Physical symptoms were strong motivators for the regular follow-up group and those
who reported physical symptoms were 10 times more likely to return to screening after
being lost to follow-up (Truesdale & Goldstone, 2010). The severity of diagnosis was
related to more compliance with screening. Those having regular follow-up were more
likely to have HSIL and those with HSIL were 4 times more likely to be having regular
follow-up than those with LSIL (Truesdale & Goldstone, 2010). Being concerned about
anal cancer was higher in HIV-infected men (D'Souza, et al., 2008) and those having a
history of anal warts in the last 6 months or ever (D'Souza, et al., 2008). Willingness to
have screening was lower when men were concerned about accuracy of the test,
embarrassed about asking for or having the pap test (Reed, et al., 2010).
Sexuality
Two of the studies investigated some aspect of sexual function or beliefs. The patients
who participated in regular follow-up were two times more likely to agree that ‘finding
out I had HPV made me feel promiscuous’ (Truesdale & Goldstone, 2010). Those who
were recalled for further investigation rated their anal health lower than those who did
not need further investigation (Landstra, Ciarrochi, Deane, et al., 2012).
2.4.3 Evaluation of Screening Procedure
One study directly investigated the acceptability of the self collected Dacron swab
screening procedure (Botes, et al., 2011). The anonymous evaluation found that 53%
rated the swab easy to collect, 81% rated the process highly acceptable, 65% reported
no pain and 83% reported no bleeding (Botes, et al., 2011). As these questionnaires
were anonymous they were not able to investigate any factors associated with better or
worse responses and they did not ask about participant’s willingness to repeat the test.
Self-collected screening was generally acceptable and therefore has the potential to
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allow for home testing, which has the potential to reduce the costs of screening
programs.
2.4.4 Psychosocial Impact of Screening
Two studies have investigated the psychosocial impact of the screening process
longitudinally. Tinmouth et al. (2011) (study 1) used 4 time points over 6 months and
Landstra et al. (2012) (study 2) used 3 time points over 3 months (Study 2 is reported in
more detail in Chapter 3). These studies had different time lines for medical procedures
with study 1 occurring in a research context. Study 1 (Tinmouth, et al., 2011) had the
swab and HRA conducted at the same time, thereby giving all participants both
procedures and having only one time frame to wait for results. In contrast, study 2
(Landstra, Ciarrochi, Deane, et al., 2012) demonstrated a more common, two stage
screening process, where swab results determined who was recalled for HRA, thereby
requiring some participants to return and wait for results twice. Both studies found no
general impact on psychological health in terms of depression or anxiety (Landstra,
Ciarrochi, Deane, et al., 2012; Tinmouth, et al., 2011), nor effects on stress or QOL
(Landstra, Ciarrochi, Deane, et al., 2012) using GPQ’s.
There was some discrepancy between these studies regarding who is impacted
and when. Study 1 found those with anal intraepithelial neoplasia (AIN) 2/3; high grade
precancerous lesions were no more impacted than others with lesser results (Tinmouth,
et al., 2011). In contrast study 2 found that being referred for HRA led to higher worry
and subsequently those with high grade anal intraepithelial neoplasia (HGAIN; equal to
AIN 2/3) continued to be worried (Landstra, Ciarrochi, Deane, et al., 2012). The time of
most negative impact in study 1 was waiting for results to be given (Tinmouth, et al.,
2011). In study 2 waiting for further investigation by HRA was the time of most impact
(Landstra, Ciarrochi, Deane, et al., 2012). These differences may be due to study 1
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using GPQ’s and study 2 using TSPQ’s. Alternatively, it may have been due to study 1
having both the swab and HRA completed in one visit while study 2 followed a two
step screening process.
Other results of importance in the studies are that participants who received
negative results from the HRA were more optimistic about their future health than those
who did not need an HRA (Landstra, Ciarrochi, Deane, et al., 2012). Thus, negative
results may lead to “unrealistic optimism” a phenomenon that is elaborated on further in
the discussion section. Characteristics that were predictive of greater worry were being
younger, having more HIV symptoms and greater baseline psychological distress
(Tinmouth, et al., 2011). Both studies demonstrated that there is some psychosocial
impact from anal cancer screening, namely increased worry and concern and this is
similar to prostate and cervical screening.
2.4.5 Limitations of the Studies
These studies have a number of limitations in common. All studies were completed with
gay men only and did not include other at risk populations, such as women with HIV or
prior HPV related cervical disease and immunosuppressed transplant recipients. Most
participants were Caucasian, well educated, and in some studies most had private health
insurance. These characteristics may not reflect the general MSM or HIV-infected
population. The vast majority of studies used different questionnaires and therefore
could not be compared. Participants were voluntary or convenience samples which may
have skewed the results towards participants who were more interested, knowledgeable
or more connected to the gay community (Pitts, et al., 2007). Hypothetical statements
were used by Reed (2010) and these could have failed to anticipate barriers to
screening. The availability of screening was not independently determined in D’Souza’s
study (D'Souza, et al., 2008) and therefore the lower perceived screening availability

Page | 27

may not reflect the actual availability of screening programs. The two longitudinal
screening studies (Landstra, Ciarrochi, Deane, et al., 2012; Tinmouth, et al., 2011) used
different medical process timelines and swab collection procedures (self collected vs.
clinician collected), making comparison between them difficult.
2.5 DISCUSSION
2.5.1 Summary of Results
Anal cancer screening appears to generate health worries specific to the procedure. Thus
far, research suggests no acute or clinically significant levels of mental health problems
as a result of screening. Most screening participants experienced no significant
psychosocial impact, but there was some individual variation, suggesting some with
particular characteristics were affected more than others. Having worse anal or HIV
symptoms, being younger, higher baseline distress or worse histology results were
predictive of greater worry. Worry in this context involved repetitive thoughts about the
screening and the possibility of having anal cancer. Furthermore, there was generally
poor knowledge of anal cancer, anal pap testing and HPV or other risk factors and low
willingness or intention to screen.
2.5.2 Clinical Implications: What to Consider When Setting Up Routine Anal
Cancer Screening
Education
Given the low levels of knowledge in the MSM’s studied and its links to screening
adherence, it is important to have targeted education campaigns about the risk of anal
cancer and the need for screening. This education is particularly important for high risk
groups such as HIV-infected MSM. Raising knowledge may increase concern and
perceived vulnerability and therefore increase motivation to have screening. Striking the
balance between raising awareness and inducing fear is important as some levels of
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worry may cause avoidance. For example, women at high risk of breast cancer with
mild distress were more likely to have screening than those with moderate distress (Hay,
Buckley, & Ostroff, 2005). Hay et al. (2005) conclude that cancer worry increases the
likelihood of screening but fear of positive results or the test itself may deter screening.
Primary care physicians were the most common point for sexual health
screening and potential contacts for anal cancer screening. Thus, primary care
physicians are critical to educational efforts and to encouraging screening. It has been
suggested that, “primary care physicians should be prepared to counsel their patients
about the pros and cons of anal cancer screening and be familiar with anal health
services in their local communities” (D'Souza, et al., 2008).
Information about the costs of screening and follow-up care need to be part of
educational campaigns. In areas where there are few public or affordable opportunities,
policy advocacy could be very important. While there are a number of research studies
on anal cancer screening, there is still debate about cost effectiveness and guidelines for
regular screening. Despite such debate, most countries have a need to increase the
availability of screening and skilled clinicians in the follow-up of abnormal anal
cytology results.
Managing the screening process
The screening process itself needs to have clear and appropriately pitched education
materials. Having communication regarding the procedure itself, expected adverse
events, recovery and non technical explanations of results are essential to support the
participants (McCaffery et al., 2004; Sharp et al., 2009; Shaw, et al., 1999). The
potential benefits of information are reflected in findings from cervical screening.
Providing written information about the meaning of an abnormal pap smear resulted in
less anxiety and fewer patients thinking they had cancer (Wilkinson, Jones, & McBride,
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1990). Written and verbal explanations of abnormal pap smear results led to better
understanding of results and better attendance for follow-up colposcopy than written
information alone (Wilson & Hines, 2000).
The choice of materials to gather the swab is also important. Such choices
require a balance between the need for good quality specimens and methods that reduce
discomfort as part of the collection process. Inadequate specimens have the potential to
increase anxiety if results are inconclusive (French, et al., 2004). In the evaluation of
self collected Dacron swabs, 35% reported some level of pain and 17% reported some
level of bleeding (Botes, et al., 2011). In another study, 12% reported that the screening
was too painful to be worthwhile (Truesdale & Goldstone, 2010). Some clinics use a
cytobrush which gathers more satisfactory specimens and may also be more painful and
lead to more bleeding. The vigour which is used in collecting the specimen may also
have an impact. Making sure participants are sufficiently prepared for the method used,
potential adverse events and level of pain is important, to increase the probability for
that person to return for screening. It is also important given they may also talk within
their social networks and provide word of mouth recommendations or warnings.
Providing the option of self-collection rather than clinician collection may give the
participant control over the level of pain. Where there is poor availability of screening,
doing home screening with self-collection may be an alternative method to reach those
at risk.
Support after screening and results
Waiting for results and further investigation were the times of greatest psychosocial
distress. It is these times that participants could benefit from support. Different types of
support may be needed by different people. Where possible it would be helpful to have
a variety of support options available such as written information, support staff
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available by phone or email, patient support groups or access to a psychologist or social
worker. We have developed a stepped care model outlined in Table 2.2 to offer
suggestions for how to triage those who may need extra support beyond information
(Bower & Gilbody, 2005).

Table 2.2 Stepped Care Model for Support following Results
Result

Level of worry

Intervention

Low worry

No further intervention

High worry or

Give written & verbal information about results

Presence of risk

and prevention efforts

Cytology
Negative

factors*
Non-negative

Low worry

Offer written & verbal information about results
and prevention efforts

High worry or

Give written & verbal information about results

Presence of risk

and prevention efforts

factors*

Give contact details for additional support and
written information on coping strategies

Histology
Negative

Low worry

Offer written & verbal information about results
and prevention efforts

High worry or

Give written & verbal information about results

Presence of risk

and prevention efforts

factors*

Give contact details for additional information &
support

Precancerous

Low worry

lesions

Give written & verbal information about results
and prevention efforts

High worry or

Give details of result & treatment plan in written,

Presence of risk

verbal & recorded format. Give details of support

factors*

group, psychologist or availability of other
clinicians (nurse, social worker) if required
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Result

Level of worry

Intervention

Cancer

Low & High

Give details of result & treatment plan in written,

worry

verbal & recorded format. Give details of support
group, psychologist or other available clinicians
(nurse, social worker) if required before
transition to oncology services

* Risk factors: younger age, physical anal symptoms, HIV symptoms, higher baseline
distress

Recognition of risk factors for psychosocial distress is an important part of this
process (e.g., younger age, physical anal symptoms, more HIV symptoms, higher
baseline distress, and worse screening results). Using TSPQ was more sensitive than
GPQ. For example, the distress thermometer, cancer worry scale, or impact of events
scale may be quick and easy ways to check level of distress or concern at the time of
screening. Those with higher levels of baseline distress should be linked to available
supports or encouraged to call for support. Other indicators that participants are at risk
of a more negative response to screening might include a lack of information seeking
(raising concerns of avoidance) or the expression of excessively negative emotions
about their results (Lauver, Kruse, & Baggot, 1999).
Similar to the lack of universally accepted protocols for screening, treatment
protocols are also not well established as there is an absence of data from randomized
treatment trials of HGAIN showing reduction of anal cancer. One post screening option
is active surveillance with no active treatment but ongoing monitoring and assessment.
It is estimated that half the men diagnosed with early prostate cancer have unnecessary
treatment that has many physical side effects and negative effects on QOL (Pickles, et
al., 2007). Similar concerns may be present for precancerous anal lesions which have
significant natural regression rates suggesting they may not worsen with time. Some
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clinicians may take an active surveillance approach rather than treatment. If this is the
case there are some strategies which can be implemented to support the patient. In a
review of active surveillance for early prostate cancer Pickles et al. (2007) found that
this option creates anxiety, but audio-taping treatment consultations for the patient
improved understanding and decision making. The doctor’s role in creating clear “rules”
about when to initiate treatment and ways to gain quality information were also
important. Another strategy is to actively manage the anxiety that may be created by
uncertainty and withholding active treatment. Options such as support groups or
therapeutic groups focused on teaching mindfulness, stress management and other
psychological therapies could be offered. One promising therapeutic approach is
Acceptance and Commitment Therapy, which helps participants to focus on accepting
uncertainty and living a vibrant and valued life even with the ongoing threat of cancer.
Use of acceptance based coping strategies, after receiving abnormal cervical pap smear
results was associated with lower psychological distress (Lauver, et al., 1999).
Supporting return for repeat screening
Empirically supported screening guidelines have not been clearly established but, as
with other cancer screening programs, regular screening may be important. Therefore
being able to motivate participants to return is imperative. Finding the balance between
reassurance and complacency is essential (Carlsson, et al., 2007; Landstra, Ciarrochi,
Deane, et al., 2012). A concern in the screening process is the phenomenon of
“unrealistic optimism” which has been found to hinder protective health behaviours.
Intentions to participate in breast screening were lower when unrealistic optimism was
higher (Barnoy, Bar-Tal, & Treister, 2003). Three years after colorectal screening, the
group who were reassured with negative results had significant increases in their body
mass index compared to those with positive results (Larsen, Grotmol, Almendingen, &

Page | 33

Hoff, 2007). This may reflect unrealistic optimism and a resulting tendency to be less
vigilant in following protective behaviours after being reassured. To protect against this
phenomenon, clinicians could emphasize known risks such as HIV and HPV infection,
numbers of sexual partners, unprotected receptive anal intercourse, and potential
consequences of progression to anal cancer. Truesdale and Goldstone (2010) highlight
the need to stress the importance of repeat screening so the participant “hears” the
message without becoming too alarmed. They found participants who were more
emotionally upset at diagnosis returned for regular follow-up. They also recommend a
reminder system be “more extensive than a mailed reminder card or short telephone
call”. Unnecessary mortality might be prevented by setting clear expectations for
regular screening at the initial screening and result-giving stages and then following up
with detailed information and reminders including assertive follow-up of those who do
not return.
2.5.3 Future Directions
Areas needing further research are impacts of screening on HIV-infected women,
women with prior HPV related cervical disease and immunosuppressed transplant
recipients, who are also at high risk. Research is also needed to examine the impact of
screening on sexual functioning and related emotional responses, such as shame,
embarrassment and self-stigma, as both cervical and prostate cancer have shown this to
be an issue. For example, does self-stigma prevent people from seeking screening, and
if so, how can this barrier be addressed? There is a need to determine what types of
support are most effective and we propose the stepped care model outlined in Table 2.2
as a starting point to develop this research, with a particular focus on motivating regular
screening.
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2.5.4 Conclusions
Anal screening does not appear to have a general impact on mental health, but in some
instances does appear to increase health-related worry. A small proportion of people
will need support and the most effective ways to do this have not yet been empirically
tested. In order to identify those who will need support, it would be useful to have
consensus on a core set of psychosocial screening measures and to establish cut off
points that provide guidance about appropriate levels of response. Similar suggestions
emerged from a review of prostate cancer screening (McNaughton-Collins, WalkerCorkery, et al., 2004). As anal cancer screening is not yet well established there is an
opportunity to set up a consistent and evidence-based approach to measuring and
responding to the psychosocial effects of screening.
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CHAPTER THREE
THE PSYCHOLOGICAL IMPACT OF ANAL CANCER
SCREENING ON HIV-INFECTED MEN2

2

This chapter is based substantially on Landstra, J. M. B., Ciarrochi, J., Deane, F. P.,

Botes, L.P. & Hillman, and R.J. (2012). Psychological impact of anal cancer screening
on HIV-infected men. Psycho-Oncology. doi: 10.1002/pon.3040

Page | 36

3.1 ABSTRACT
Background: Anal cancer rates are increasing in HIV-infected men. Screening
programs similar to prostate and cervical cancer have been recommended to reduce
morbidity and mortality. Research shows that screening processes have psychological
consequences which need to be considered. Limited investigation of the psychological
impact of anal cancer screening has been conducted.
Methods: A prospective longitudinal survey of 291 men was conducted at three time
points over 14 weeks at a public HIV clinic in Sydney, Australia. Self report
questionnaires measuring worry, distress, depression, anxiety, stress, and health related
quality of life (SF-12) were collected.
Results: Those who had a biopsy recommended were significantly more worried about
anal cancer, rated their anal health worse and were less optimistic about their future
health than the control group who needed no further medical investigation. The group
receiving high grade histology results remained worried about anal cancer at time three.
We found no evidence that general anxiety, depression or quality of life was
significantly affected by the process.
Conclusions: Anal cancer specific worry increases throughout the screening process.
Clear communication prior to procedures about the procedure itself, potential adverse
events, the recovery process and non technical explanations of results should be
implemented in anal screening programs.
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3.2 INTRODUCTION
Increases in anal cancer prevalence, especially in specific populations such as HIVinfected individuals and men who have sex with men (MSM) have increased awareness
of this disease. There is a growing concern that screening, prevention and early
intervention efforts need to be implemented as they have been in cervical, breast and
prostate cancers (Darragh & Winkler, 2011). The New York State AIDS Institute
Guidelines (2007) for management of HIV-infected individuals recommend baseline
and annual follow-up anal cytological screening. While screening programs have the
potential to reduce morbidity and mortality in some individuals, they also have the
potential to decrease psychological well-being, due to uncertainty associated with
screening, procedures and results (Barratt, et al., 2002; McCaffery & Barratt, 2004;
McNaughton-Collins, Fowler, et al., 2004; Shaw, et al., 1999; Stewart-Brown &
Farmer, 1997). This aspect of anal cancer screening has not been investigated.
The anal cancer disease and screening process is similar to the highly effective
cervical cancer model (Darragh & Winkler, 2011). Psychological costs and implications
of cervical cancer screening have been demonstrated by many studies. Screening
increases anxiety, worry about cancer, and can be detrimental to sexual well-being
(French, et al., 2004; Gray, et al., 2006; Wardle, et al., 1995). It is not only high grade
results that have adverse impacts (Wardle, et al., 1995). Low grade results have also
been shown to have a negative psychological impact (Gray, et al., 2006) and
“inadequate specimen” results are associated with increased anxiety. In turn, return for
repeat testing is lower in those who are most anxious (French, et al., 2004).
Similar results have been found in breast cancer screening studies (Brett, et al.,
2005). Worry about breast cancer persists even after receiving reassurance of a false
positive mammogram and there are increased reports of self examination and higher
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interference with mood and daily functioning (Lerman, Trock, Rimer, Boyce, et al.,
1991; Lerman, Trock, Rimer, Jepson, et al., 1991). Prostate cancer screening studies
report similar findings (Pickles, et al., 2007). Worry about cancer persisted amongst a
group of men after negative biopsy results were received and more medical follow-up
was sought by this group than the control group who did not have a biopsy (Fowler, et
al., 2006; McNaughton-Collins, Fowler, et al., 2004).
Anal cancer and its potential burden of disease particularly in the HIV-infected
and MSM population have gained prominence in the last 5-10 years (Herat, et al., 2007;
Palefsky, 2007). Many screening and treatment studies have been conducted around the
world (Chin-Hong, et al., 2008), but little empirical research has focused on the
psychological implications of the screening process. Only one study focussed on the
psychological effects of screening (Tinmouth, et al., 2011). They found that most
participants were not significantly impacted by the process and the most difficult aspect
was waiting for the results. In this study the swab and high resolution anoscopy (HRA)
were completed at the same time which may have reduced the potential effects.
Typically, the screening process involves two stages; a swab and if further investigation
is warranted from swab results, an HRA to determine the extent of disease. It is during
the three waiting periods for results and an HRA that patients may experience increased
stress and worry about the potential for “bad news”. There is a need to assess the
psychological effects of this screening under more naturalistic conditions.
Other studies have investigated barriers and facilitators to MSMs accessing anal
cancer screening (Newman, Roberts, Masongsong, & Wiley, 2008), MSM’s knowledge
of anal cancer and human papillomavirus (HPV; Pitts, et al., 2007) and factors affecting
follow-up rates after screening (Truesdale & Goldstone, 2010). It is possible that being
HIV-infected desensitises this population to other health issues. The aim of our study
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was to investigate the psychological impact of a naturalistic anal cancer screening
program. We utilised a prospective longitudinal design using standardised measures
adapted from previous cervical and prostate cancer screening studies.
3.3 METHODS
3.3.1 Design and Procedures
A multi-wave longitudinal study of 291 HIV-infected MSM undergoing anal cytological
screening at St Vincent’s Hospital in Sydney, Australia was conducted from October
2008 to April 2010. The study was approved by the human research ethics committee of
the hospital and informed consent was obtained from all participants. Any HIV-infected
MSM who attended the HIV clinic during the study period were eligible. Exclusion
criteria included a significant bleeding disorder, anal pathology likely to render an anal
swab significantly uncomfortable, and being unable or unwilling to give informed
consent.
The study consisted of three stages as illustrated in Figure 3.1 (Appendix One
contains a more comprehensive participant flow chart). The medical aspects of the
screening study began with a sexual health research nurse (Leon Botes) conducting a
detailed history of sexual and anal health, and giving instructions regarding the self
collection of swabs for anal cytology and anal bacterial sexually transmitted infections.
The cytology results were delivered based on participant’s preferences (phone, mail, email or in person). Participants whose swab yielded cytology results that were
technically unsatisfactory were invited to have a second swab. Participants with
negative or Low Grade Squamous Intraepithelial Lesion (LSIL) cytology results formed
the control group. Further investigation by high resolution anoscopy (HRA) was offered
to participants whose cytology results were; High Grade Squamous Intraepithelial
Lesion (HSIL), Atypical Squamous Cells-Cannot exclude HSIL (ASC-H), or Atypical
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Squamous Cells - Unknown Significance (ASC-US). The HRA procedure is similar to
colposcopy investigation of cervical smear abnormalities. Following the HRA
procedure, histology results were given in person or by mail and follow-up options
discussed.
The psychological impact assessments occurred at the three stages of the
medical process. The first questionnaire pack was given at the initial interview, to be
completed that day and mailed back. The second and third questionnaire packs were
mailed in the week the participant received their cytology and histology results,
approximately two weeks after the respective procedure. The control group were not
offered an HRA, but were sent the third questionnaire pack at a time matched interval of
approximately 12 weeks. The questionnaire packs consisted of a variety of well
standardised measures as outlined below and took 20-30 minutes to complete. Identical
questionnaire packs were used, except questionnaire pack three for the HRA group,
which contained additional questions about their HRA experience (Appendix Two).
3.3.2 Participants
The anal screening study sample consisted of 291 men, of whom 287 (99%) participated
in the psychological impact study as outlined in Figure 3.1. The individual
questionnaire response rates were 94% (271/287) at baseline, 84% (220/263) at time
two after cytology, and 79% (50/63) at time three for the group receiving histology
results, and 82% (113/138) for the control group. Some participants had an HRA
(n=11) off protocol for investigation of warts, some declined an HRA (n=5) and others
withdrew from the study (n=5). These participants along with those who did not
complete all three questionnaires (n=97) were excluded from the analysis. Full followup data were available from 57% (163/287) of the participants given the baseline
questionnaire as indicated in Figure 3.1.
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Cons ent, inte rvi ew,
swab, bl ood te st &
Que st ionnai re One
N=287

Comple te d n =271
94% of N

C yt ol ogy Re sult
Ne gat i ve & LSIL
n= 179 (62%)

Unsat is fa ct ory Swa b
n=6 (2%)

Cytol ogy R es ul t
ASC -US, ASC -H &
HSIL n=86 (30%)

Quest ionna ire Two
n=178

De cl ine d repe at swab
n=5
Una bl e t o col le ct n= 1

Que sti onnai re Two
n=85

Comple t ed n=149
52% of N

Comple t ed n=71
25% of N

No Me di c al Fol low-up

HR A Proc e dure n=66
R es ul ts re ce i ved 2
we eks l at er

Hi stol ogy Re sult s
No B iopsy, Negat ive ,
L SIL, Wart Vi rus &
Ot he r n=28

His tol ogy Re sul ts
HGAIN n=38
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n=138
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n= 27
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n=36

Comple te d n=113
39% of N
Low Threa t Group

Comple te d n=22
8% of N
R eas sure d Group

C ompl et e d n=28
10% of N
High Threa t Group

Figure 3.1 Study Flow Diagram
Percentages are of original sample (N=287) at each subsequent time point.
LSIL= Low Grade Squamous Intraepithelial Lesion; HSIL = High Grade Squamous
Intraepithelial Lesion; ASC-US = Atypical Squamous Cells: Unknown Significance;
ASC-H = Atypical Squamous Cells: Cannot exclude HSIL; HRA= High Resolution
Anoscopy; HGAIN = High Grade Anal Intraepithelial Neoplasia
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3.3.3 Measures
The Anal Screening Questionnaire (ASQ) was created by modifying the Cervical
Screening Questionnaire (CSQ; Wardle, et al., 1995). As no research has been
conducted in the anal screening field, we sought permission to utilise this validated
measure, substituting “anal” for “cervical”. Questions cover general and anal health,
body image, sexual interest and optimism about future health, with items rated on a 4point Likert scale. The worry questions from the CSQ were omitted and the adapted
prostate cancer worry items from McNaughton-Collins et al. (2004) were used. This
measure assesses worry about cancer, dying soon, and reassurance from testing. In the
present study Cronbach alpha for the cancer worry scale was α=.71.
The Distress Thermometer is a single item utilising a Likert type scale from
0=No distress to 10=Extreme Distress (Jacobsen, et al., 2005). It measures subjective
distress in relation to specific aspects of the screening process such as, “waiting for the
swab results” or “since the HRA results”. A similar distress measure is used in
Oncology (Jacobsen, et al., 2005), and has demonstrated the ability to quickly and easily
identify distress levels. A cutoff score of 4 yielded optimal sensitivity and specificity
relative to established cutoff scores on the Brief Symptom Inventory and Hospital
Anxiety and Depression Scale (Jacobsen, et al., 2005).
Medical Outcomes Study Short Form Health Survey (SF-12) is a measure of
health related quality of life (QOL) that is well validated in Australia (Andrews, 2002;
Sanderson & Andrews, 2002). Two summary scales of physical (PCS) and mental
(MCS) well-being are generated using the brief integer scoring method developed by
Andrews (2002).
The Depression Anxiety Stress Scale (DASS 21; Lovibond & Lovibond, 1995)
measures depression, anxiety and stress. Items such as, “I felt scared without any good
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reason”, are rated on a 4-point Likert scale. The measure has been used with general,
clinical and HIV-infected populations and has good internal consistency, validity and
test-retest reliability (Henry & Crawford, 2005; Lovibond & Lovibond, 1995). In the
present study Cronbach alpha for the depression scale was α=.94, anxiety scale α=.88
and stress scale α=.92.
3.3.4 Statistical Analyses
The principal analysis was repeated measure ANOVAs to investigate mean scores and
differences between groups at each time point. We also performed chi-squares to
compare our results with similar studies in other health domains. All analysis was
completed using SPSS version 17 for Windows (SPSS Inc, Chicago, Illinois) with a
significance level of p < 0.05.
3.4 RESULTS
3.4.1 Participants
Missing value analysis revealed no significant differences between those who
completed every wave of the study (completers) and those who did not complete every
wave (non completers) on the psychological impact variables, all ps > .05. There was a
significant age difference F (1, 279) = 12.46, p<0.001 between the completers (M = 52
yrs) and non completers (M = 48 yrs). There were no significant differences in
demographic characteristics between the control and HRA groups. Therefore, the
demographic details for participants included in the analysis have been summarised as a
total group (Table 3.1). The participants were for the most part middle aged Caucasian
men, with most of them working and half reporting a long term relationship.
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Table 3.1 Demographic Characteristics of Participants.
Characteristic
Mean Age (SD; Range)

Frequency
52 (9; 28-73)

Education (%)
High school or less

56 (34)

Certificate/Diploma

25 (16)

Bachelor Degree

54 (33)

Post graduate

28 (17)

Relationships (%)
Currently in a relationship

78 (49)

Time in relationship > 5 years

65 (83)

Median sex partners in last 12 months (SD; Range)

5 (31; 0-240)

Employment (%)
Full time

86 (53)

Part time/Casual

25 (16)

Student

1 (1)

Retired

15 (9)

Unemployed

35 (21)

HIV Characteristics (SD; Range)
Mean years HIV- infected
Antiretroviral medication (%)
Mean years on antiretroviral medication
Median current CD4 count (cells/µl)
Median current HIV viral load (copies/ml)

15 (8; 1-27)
151 (93)
10 (6; 1-22)
486 (230; 69-1634)
50 (22001; 5-265000)

Current Anal Symptoms (%)
Pain

17 (10)

Discharge

7 (4)

Bleeding

47 (29)

Itch

38 (23)

Lumps

21 (13)

Past History Anal Disease (%) (self report)
Anal HPV

75 (46)

Anal Fissures

24 (15)
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Characteristic

Frequency

Anal Intraepithelial Neoplasia

3 (2)

Current smoker (%)

44 (27)

Illicit drug use in last 24 months (%)

80 (49)

Current alcohol drinker (%)

138 (85)

Antidepressant Medication (%)

12 (7)

HIV= human immunodeficiency virus; HPV= human papillomavirus
3.4.2 Group Differences
Based on cytology and histology results, three groups were formed. The “low threat”
group (n=113) received cytology results of negative or LSIL. The “reassured” or false
positive group (n=22) required an HRA and either needed no biopsy or had reassuring
histology results such as negative, warts or “other inflammation”. The “high threat”
group (n=28) required an HRA and received high grade anal intraepithelial neoplasia
(HGAIN) histology results.
The differences in psychological responses were investigated between these
groups across the three time points. One way ANOVAs and analysis of mean scores
were used to investigate the group differences. There were no significant differences at
baseline (Figures 3.2, 3.3, 3.4). At time two and three, there were significant group
differences for cancer worry, anal health ratings, optimism for future health and distress
after receiving histology results. The differences in cancer worry can be seen in Figure
3.2. At time two the groups recommended for HRA (reassured and high threat) had
higher levels of worry than the low threat group, F (1, 143) = 37.56, p<0.001, η2 = 0.21.
At time three the high threat group continued to have higher levels of worry, whereas
the reassured group dropped below the high threat group but remained significantly
above the low threat group, F (2, 159) = 16.59, p<0.001, η2 = 0.17. Figure 3.3 illustrates
anal health ratings were only significantly different at time two, with anal health rated
significantly worse by the HRA groups, F (1, 157) = 14.22, p<0.001, η2 = 0.08.
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Optimism for future health (Figure 3.4) was significantly different at time two, with the
low threat group rating higher optimism compared to the HRA groups, F (1, 158) =
8.40, p =0.004, η2 = 0.05. At time three, the reassured group became more optimistic
about their health than either the low threat or high threat group, F (2, 158) = 3.19, p =
.04, η2 = 0.04. Distress levels after receiving HRA results revealed that the high threat
group experienced more distress than the reassured group, F (1, 43) = 5.65, p = .02, η2 =
0.12. There were no significant differences between the groups at any time point for
ratings of depression, anxiety, stress and physical or mental quality of life, p >0 .05.

2
1.8

Low Threat
Reassured
High Threat

Worry Level

1.6
1.4
1.2
1
0.8
T1: Baseline

T2: Cytology Result

T3: Histology Result

Time

Figure 3.2 Cancer Worry by Threat Groups at 3 Time Points.
T1= Time One, T2=Time Two, T3= Time Three
The reassured (dashed line) and high threat (solid line) groups were both recommended
for HRA, therefore the groups are merged at T1 & T2. Cancer worry scale consisted of
6 items. The time intervals between T1-T2 =2 weeks, T2-T3 =10-12 weeks.
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2.2

Anal health rating

Low Threat
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T2: Cytology Result
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Figure 3.3 Anal Health rating by Threat Groups at 3 Time Points.
T1= Time One, T2=Time Two, T3= Time Three
The reassured (dashed line) and high threat (solid line) groups were both recommended
for HRA, therefore the groups are merged at T1 & T2. This single item was rated with a
4 point Likert scale, better than usual to much worse than usual. The time intervals
between T1-T2 =2 weeks, T2-T3 =10-12 weeks.

Page | 48

Optimism for future health

2.2

Low Threat
Reassured
High Threat

2

1.8

1.6
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T2: Cytology Result

T3: Histology Result

Time

Figure 3.4 Optimism about Future Health by Threat Groups at 3 Time Points.
T1= Time One, T2=Time Two, T3= Time Three
The reassured (dashed line) and high threat (solid line) groups were both recommended
for HRA, therefore the groups are merged at T1 & T2. This single item was rated with a
4 point Likert scale, better than usual to much worse than usual. The time intervals
between T1-T2 =2 weeks, T2-T3 =10-12 weeks.

3.4.3 Comparison to Other Studies
We next compared our results with prostate and cervical studies, to examine whether
anal screening produced similar levels of distress as other, similar screening procedures.
We utilized 2 x 2 chi squares to examine the extent that participants felt high (a lot,
some) vs. low levels (not at all, only a little) of worry. As these were exploratory tests
we used a Bonferroni corrected alpha p=0.004 (.05/12) and p=0.003 (.05/15)
respectively to control for the number of comparisons. Our results suggest the level of
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worry in the present sample is similar to that found in a prostate screening sample
(McNaughton-Collins, Fowler, et al., 2004).
We next compared our results to Wardle et al. (1995), who investigated the
psychological impact of cervical screening results. For the question, “is there a
beneficial effect of a negative smear”, there were no significant differences between
Wardle’s data and ratings in our study.
For the question, “is there a detrimental effect of mild or positive smear results”,
we found differences in three items. In the groups receiving negative results there were
no differences. In the mild abnormality groups there were differences in ratings of
anal/gynaecological health with the cervical group reporting worse health (32%) than
the anal group (6%), X2(1, N=123) = 13.56, p<0.001. Between the groups referred for
colposcopy/HRA there were differences in ratings of control of your body, ratings were
worse for the cervical group (43%) compared to the anal group (8%), X2(1, N= 64) =
10.08, p<0.001. Optimism for future health was also worse for the cervical group (71%)
compared to the anal group (24%), X2(1, N=64) = 10.91, p<0.001.
In summary, in the mild abnormality groups there was more threat experienced
by women regarding gynaecological health. In the colposcopy/HRA groups the women
felt less in control of their body and less optimism for future health compared to the
men in our study.
3.5 DISCUSSION
We investigated the psychological impact of an anal cancer screening program using
prospective self report questionnaires at three time points in the medical process. The
high threat and reassured groups who were invited to have an HRA were significantly
more worried about anal cancer, rated their anal health worse and were less optimistic
about their future health than the control group who did not need further investigation.
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These findings are similar to women receiving cervical cytological screening (Wardle,
et al., 1995) and men receiving prostate biopsy screening (McNaughton-Collins,
Fowler, et al., 2004). Our results could not be directly compared to the Tinmouth study
(2011) of anal cancer screening as the measures and order of medical processes were
different. Tinmouth et al. (2011) used the Impact of Events Scale, measuring stress; the
Illness Intrusiveness Ratings Scale, measuring psychosocial impact on quality of life;
and the positive questions from the Psychological Consequences Questionnaire adapted
from mammography.
We found no evidence that general anxiety, depression or quality of life was
significantly affected by the process. Thus, the psychological consequences appeared
restricted to health related concerns. The participants were all HIV-infected, which may
have contributed to the finding that general mood states did not differ throughout the
process. The distressing aspects of this process could be perceived as minor in
comparison to what they have dealt with during their HIV diagnosis and management.
Additionally, they may be accustomed to regular testing regarding their HIV infection
such that this was just another routine screening process and their overall well-being
was not threatened.
Interestingly, in the ratings of optimism for future health, the reassured group
rebounded in optimism and indeed was more optimistic than both the high threat group
and the low threat group who had not received a health scare. One possible explanation
for this is that a negative result after a thorough screening for a physical problem
(reassured group) is more reassuring than a negative result after a brief screen (low
threat group). This possibility is supported by a study showing that 30% of
asymptomatic individuals invited to have colorectal screening showed significant
mental health benefits 5 weeks after screening (Taupin, Chambers, Corbett, & Shadbolt,
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2006). Men with a family history of prostate cancer or who believed they had a greater
chance of developing prostate cancer were more reassured by the thorough testing
option than the brief screen when rating hypothetical scenarios (Cantor, Volk, Cass,
Gilani, & Spann, 2002).
A second explanation is that the reassured group might have felt that they had
“dodged a bullet” and this led them to feel particularly optimistic. The phenomena of
“unrealistic optimism” UO has been found to hinder protective health behaviours.
Intentions to participate in breast screening were lower when UO was higher (Barnoy, et
al., 2003), UO was higher in older smokers who inaccurately rated their health risks and
they had less intention to quit than those with no UO (Dillard, McCaul, & Klein, 2006).
Three years after colorectal screening the group who were reassured with negative
results had significant increases in their body mass index compared to those with
positive results (Larsen, et al., 2007). This may reflect UO and a resulting tendency to
be less vigilant in following protective behaviours after being reassured. Future research
could investigate these possible explanations in screening studies. Information about
future risk could be important to encourage reassured individuals to repeat testing as
recommended.
We found that although the screening increased cancer specific worry, it did not
raise general levels of anxiety or mental health problems. These results are different
from what has been found with cervical screening, which shows threatening Pap smear
results are associated with subsequent increases in general anxiety (Essink-Bot, et al.,
1998; Gray, et al., 2006; Wardle, et al., 1995). However, our results are similar to
findings by Essink-Bot et al. (1998) that general anxiety was not altered by the prostate
screening process. Future research is needed to investigate whether the difference was
due to sex, site of problem, or other aspects of the population. Studying HIV-infected
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women undergoing anal cancer screening is one possible way of investigating these
differences.
Similar to prostate and breast screening studies (Lerman, Trock, Rimer, Jepson, et al.,
1991; McNaughton-Collins, Fowler, et al., 2004), we also found that worry specific to
the process and disease was different between the three groups. The level of worry in
our sample was similar to McNaughton et al.’s prostate sample (2004) and because we
had baseline data we were able to measure the influence of the procedures on worry
levels. We found that the reassured group were more worried than the control group at
time three, but that their worry levels had dropped considerably since being referred for
HRA.
Our results need to be viewed with caution, as the sample was of mainly well
educated Caucasian men living in the inner city. While response rates were adequate,
the attrition rate through the various processes meant that only 57% of the initial
participants were included in the analysis, this may have biased our results towards
those who were more or less affected. We did not have an experimental control group
who did not have any screening, or the ability to screen the low threat group with the
same thorough process. Our study used self collected swabs, rather than clinician
collected, which is not always the method used, however 81% of the participants who
completed the anonymous evaluation form rated self collection as acceptable (Botes, et
al., 2011); self collection could have added an additional element of fear or worry about
correct collection. Further, Chin-Hong et al. (2008) found that self collection vs.
clinician collection yields comparable specificity but clinician collection has higher
sensitivity. We did not gather health or information seeking behaviour which may have
been a coping mechanism and therefore moderated the impact of the procedures. For
example, one study found patients with a benign prostate biopsy had more PSA tests
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and doctor visits in the follow-up period than the control group who had no biopsy
(Fowler, et al., 2006). Patients who had an interest in HPV may have self selected into
the study. Caution needs to be taken with our comparisons to other studies as we used
descriptive analysis to broadly compare and were not able to control for the differences
between the studies.
Screening programs for anal cancer need to consider the psychological impact
on participants, particularly due to the likelihood of higher proportions of HSIL and
HGAIN results in anal screening compared to cervical screening (Darragh & Winkler,
2011; Palefsky, 2008). Our results indicate the impact is likely to be specific to health
related worry. Future studies could investigate ways to ameliorate this health worry.
One potential strategy is clear communication, demonstrated by prostate and cervical
studies of cytology and histology results processes (Fowler, et al., 2006; Gray, et al.,
2006; Wardle, et al., 1995; Wilson & Hines, 2000). Providing written information about
what an abnormal Pap smear meant, led to less anxiety and fewer patients thinking they
had cancer (Wilkinson, et al., 1990). Written and verbal explanations of abnormal Pap
smear results led to better understanding of results and better attendance for follow-up
colposcopy than written information alone (Wilson & Hines, 2000).
Future screening programs need to optimise communication regarding the
procedure itself, expected adverse events, recovery and non technical explanations of
results (Sharp, et al., 2009; Shaw, et al., 1999). For example, the distinction between
cancer and pre-cancer cytological and histological results can be difficult for patients to
conceptualise and cervical screening participants have found it, “difficult to understand
cell changes as anything other than a life-threatening illness” (Hounsgaard, et al., 2007).
Future research would benefit from using a community-derived sample of MSM,
experimenting with communication styles and investigating health seeking behaviours,
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especially with the reassured group, as past research suggests that they may decrease
their protective health behaviours (Larsen, et al., 2007). In addition having a longer
follow-up period such as 6 months may give valuable information about the
continuation of distress. Use of experience sampling for day to day emotions with smart
phone apps or handheld computers would give richer data.
Our results show that specific worry about anal cancer increases throughout the
medical process. They also suggest that receiving some threatening information and
then reassuring information may produce greater optimism than never receiving
threatening information. Further studies are needed to examine the best way to present
information to these patients.
Differences in personal characteristics such as the ability to identify and describe
feelings or psychological flexibility could contribute to differences in responses to
threatening information. These characteristics are the focus of the next part of this
thesis.
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CHAPTER FOUR
IDENTIFYING AND DESCRIBING FEELINGS AND
PSYCHOLOGICAL FLEXIBILITY PREDICT MENTAL
HEALTH IN MEN WITH HIV 3

3

This chapter is based substantially on Landstra, J. M. B., Ciarrochi, J., Deane, F. P. &

Hillman, R. J. (2013). Identifying and describing feelings and psychological flexibility
predict mental health in men with HIV. British Journal of Health Psychology.
doi:10.1111/bjhp.12026
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4.1 ABSTRACT
Background: Difficulty identifying and describing feelings (DIDF) and psychological
flexibility (PF) predict poor emotional adjustment.
Objective: To examine the relationship between DIDF and PF and to determine
whether DIDF and low PF would put men undergoing cancer screening at risk for poor
adjustment.
Design: Longitudinal self report survey.
Methods: 271 HIV- infected men who have sex with men participated in anal cancer
screening at two time points over 14 weeks. PF was assessed by the Acceptance and
Action Questionnaire II and DIDF by the Toronto Alexithymia Scale-20. We also
measured depression, anxiety, stress (DASS-21) and health related quality of life (QOL;
SF-12).
Results: Both DIDF and PF were reliable predictors of mental health. When levels of
baseline mental health were controlled, greater DIDF predicted increases in Time 2
depression, anxiety and stress, and decreases in mental and physical QOL. The link
between PF and mental health was entirely mediated by DIDF.
Conclusions: Being chronically low in PF could lead to greater DIDF and thereby
worse mental health. Having more PF promotes the ability to identify and differentiate
the nuances of pleasant and unpleasant emotions which enhances an individual’s mental
health. Intentionally enhancing men’s ability to identify and describe feelings or PF may
assist them to better manage a range of difficult life experiences such as health
screenings and other potentially threatening information.
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4.2 INTRODUCTION
Early detection screening programs have been well established for a variety of
cancer types. More recently anal cytological screening for anal cancer has been
recommended (New York State Department of Public Health AIDS Institute, 2007).
Population rates of anal cancer are 1.6 per 100,000 (Darragh & Winkler, 2011).
However, men who have sex with men (MSM) and are HIV infected have considerably
higher rates, estimated at between 42 and 137 per 100,000 (Darragh & Winkler, 2011).
The psychological impact of cancer screening has been demonstrated in many different
programs and typically includes increased anxiety, reduced quality of life and increased
health vigilance (Brett, et al., 2005; Gray, et al., 2006; McNaughton-Collins, Fowler, et
al., 2004). Strategies for reducing these effects involve clear communication in written
and verbal forms about the procedures and results (Wilkinson, et al., 1990; Wilson &
Hines, 2000). Another way to reduce the negative effects of screening may be to
develop an individual’s strengths (e.g., ability to identify and describe feelings and
psychological flexibility) to enhance their coping ability. There are numerous theories
that have the potential to explain how an individual copes with a health threat. Our
study focuses on the two individual characteristics the difficulty in identifying and
describing feelings (DIDF; Bagby, et al., 1994) and psychological flexibility (PF).
Difficulties in identifying and describing feelings are major components of alexithymia
(Bagby, et al., 1994). PF is “the ability to contact the present moment more fully as a
conscious human being, and to change or persist in behaviour when doing so serves
valued ends” (Hayes, et al., 2006). Both DIDF and PF have been shown to explain
differences in psychological functioning (Berrocal, et al., 2009; Gloster, et al., 2011),
physical well-being (McCracken & Zhao-O'Brien, 2010; Saharinen, et al., 2008) and
quality of life (QOL) outcomes (Hayes, et al., 2006; Modestin, et al., 2004).
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4.2.1 Identifying and Describing Feelings
As noted, the ability to identify and describe feelings is a major component of
alexithymia. Alexithymia is characterized by difficulty in naming or expressing
feelings, difficulty distinguishing between bodily sensations and feelings, and a
preoccupation with external events. Individuals with alexithymia have deficits in
identifying and communicating their feelings and show little insight into feelings,
symptoms and motivation (Lumley, Neely, & Burger, 2007). DIDF as measured by
alexithymia subscales, leads to better psychological and psychosocial functioning in
medical patients (Picardi et al., 2007) and the general population (Berrocal, et al., 2009).
Quality of life in the general population is higher when alexithymia scores are lower
(Modestin, et al., 2004; Saharinen, et al., 2008). Conversely a 5 year prospective study
in Finland found alexithymia was associated with increased mortality rates in men
(Kauhanen, et al., 1996). Thus, the ability to recognize and describe emotions is likely
to have benefits for coping with health problems. Men tend to be poorer at identifying
and describing emotions than women (Mattila, et al., 2008) and so this may be of
particular importance in the male population. Alexithymia has been associated with
increased symptoms and illness behaviours in patients with HIV (Lumley,
Tomakowsky, & Torosian, 1997) and those with fibromyalgia (van Middendorp et al.,
2008). van Middendorp and colleagues (2008) concluded, “affect intensity was related
to more severe pain only in combination with the inability to process or verbalize
emotions, suggesting that the intense experiencing of emotions is not necessarily
maladaptive as long as these emotions are adequately processed” (p.165). The ability to
identify and describe one’s feelings is helpful in coping with difficult situations; this is
illustrated by studies of alcohol consumption and treatment. In an experience sampling
study of underage drinking, Kashdan et al. (2010) found that number of drinks per
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session was related to the ability to differentiate between emotions. Moreover, in the
presence of high negative emotion intensity, those with better skills at differentiating
emotions had fewer drinks than those who were less able to differentiate (Kashdan, et
al., 2010). Better alcohol treatment outcomes have also been found to be significantly
related to lower alexithymia scores (Cleland, Magura, Foote, Rosenblum, & Kosanke,
2005). These studies illustrate that it is not the situation or particular emotion that are
important, but the individual’s ability to process them. This skill is likely to be helpful
in coping with the waiting and uncertainty of cancer screening.
4.2.2 Psychological Flexibility
As noted, PF involves the ability to be in the present moment and to behave in
ways that are adaptable and will achieve a person's values. For example a person with
more PF would not become entangled with particular thoughts, memories, physical
sensations or feelings; nor let these experiences get in the way of how they want to live
their life. Flexibility in this context involves components of acceptance and a
willingness to move forward in directions the person views as fulfilling. This is
particularly relevant for those with chronic conditions such as pain, anxiety or illness as
there are many unpleasant or painful experiences that can occur with these conditions
which cannot be changed. In a meta analysis of 32 studies, higher PF was consistently
associated with better QOL and other psychological outcomes (Hayes, et al., 2006). A
more recent review concluded that there is preliminary research evidence for the
effectiveness of Acceptance and Commitment Therapy (ACT) interventions which
enhance PF and thereby improve functioning and mental health in a number of clinical
populations such as patients with anxiety, depression, chronic pain, epilepsy and
psychotic symptoms (Pull, 2009). Another review (Ruiz, 2010) has drawn similar
conclusions, that ACT interventions enhance PF and via this change improve well-being
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and mental health for a variety of clinical populations. Additionally, the treatment effect
sizes were large and typically better at follow-up than end of therapy, showing lasting
improvements in well-being (Ruiz, 2010).
Cheng and colleagues (2003; 2005) found that students who had more flexibility
in their coping efforts were better adjusted and experienced less anxiety and depressive
symptoms. A German study comprising a mixed sample of clinical and nonclinical
participants found levels of PF were higher in the student and general population than
the clinical groups (Gloster, et al., 2011). Furthermore, PF elucidated aspects of
functioning and mental health beyond well validated measures of mental health
(Gloster, et al., 2011). Together these findings suggest that higher levels of PF are
associated with less psychopathology and better mental health. It has been theorized and
there is increasing research evidence to support the hypothesis that, “When people lack
psychological acceptance (PF) they are more vulnerable to emotional difficulties”
(McCracken & Zhao-O'Brien, 2010). This is further confirmed by research showing that
PF mediates outcomes associated with ACT interventions including; mental health and
well-being (Bond & Bunce, 2003; Donaldson-Feilder & Bond, 2004); pain (McCracken
& Zhao-O'Brien, 2010; Wicksell, Renöfält, Olsson, Bond, & Melin, 2008); social
phobia (Dalrymple & Herbert, 2007); generalised anxiety (Roemer, Orsillo, & SaltersPedneault, 2008) and depression (Forman, Herbert, Moitra, Yeomans, & Geller, 2007).
Increasing PF enabled better QOL and greater engagement in life.
Karekla and Panayiotou (2011) found that individuals with low PF used
avoidant coping methods to a greater extent, such as denial, emotional support,
behavioural disengagement, venting, and self-blame. It has been proposed that a lack of
PF may be the mechanism by which avoidant coping is detrimental and it has been
found that when levels of PF are controlled, avoidant coping and fear of uncertainty no
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longer predict psychological outcomes (Berrocal, et al., 2009). In cancer screening, use
of acceptance based coping strategies (high PF) after receiving abnormal cervical pap
smear results was associated with lower psychological distress (Lauver, et al., 1999).
Conversely, use of escape-avoidance coping (low PF) after receiving an abnormal
colorectal cancer screening result was associated with more distressing emotional
representations of the illness, increased anxiety and identification of bowel symptoms
and non-participation in screening 2 years later (Orbell et al., 2008). These studies show
a clear link between avoidance (low PF) and worse well-being.
PF involves being willing to experience unpleasant emotions without needing to
change them. If an individual is low in PF, this means they are more likely to avoid,
distract or ignore negative emotions. Such a tendency to avoid may limit their
opportunities for identifying and clearly labelling emotions. However, it is not clear
from previous research whether it is that learning to be aware of and describe emotions
allows one to be more flexible which, in turn improves functioning, or whether it is that
learning to be flexible with one's private experiences facilitates improved identification
and description of emotions, which, in turn, improves functioning? In a cross sectional
study Berrocal et al. (2009) investigated the relationship between PF and alexithymia in
predicting psychological outcomes. Even when the level of PF was controlled,
alexithymia and PF independently predicted psychological outcomes. They concluded
that alexithymia and PF were related, but independent, psychological characteristics.
4.2.3 Aims
Berrocal et al’s. (2009) study was cross sectional and used a student and
convenience sample from the general population. They suggest the need for further
research to expand understanding of alexithymia and PF. Our study provides an
extension, using longitudinal data from a medical setting. This design allows
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assessment of the extent that DIDF and PF are antecedent to the development of mental
health, rather than a mere concomitant or consequence. Furthermore it allows us to
examine mediation between these characteristics. We focused on men with HIV, who
were being investigated for anal cancer precursors. The potential for uncertainty and
distress is well documented by studies of other cancer screening programs.
We tested three models of the link between DIDF/PF, screening, and mental
health. What we call the situation effect model predicts that medical results, rather than
DIDF/PF, will determine mental health after screening. The interaction model predicts
that the effect of the medical results will depend on how much DIDF/PF the participant
displays. The resilience model predicts that DIDF/PF determines the development of
positive mental health, regardless of medical results. We also compare models that
presume DIDF is the mediator between PF and mental health with models that assume
PF is the mediator between DIDF and mental health.
4.3 METHODS
4.3.1 Participants
A prospective longitudinal study of 291 MSM infected with HIV undergoing
anal cytological screening in Sydney, Australia was conducted from October 2008 to
April 2010. The study was approved by the Human Research Ethics Committee of the
hospital and written informed consent was obtained from all participants. Any MSM
who were HIV infected and attended the HIV clinic during the study period were
eligible. Exclusion criteria included a significant bleeding disorder, anal pathology
likely to render an anal swab significantly uncomfortable, and being unable or unwilling
to give informed consent.
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4.3.2 Measures
Proposed mediators
Difficulty identifying and describing feelings (DIDF) was measured by
subscales of the Toronto Alexithymia Scale-20 (TAS-20; Bagby, et al., 1994). The scale
included items such as: “When I am upset, I don’t know if I am sad, frightened, or
angry” and “It is difficult for me to find the right words for my feelings”. Higher scores
indicate less ability to identify emotions. For the purpose of the present study, one scale
was formed by combining the 12 items rating difficulty identifying and describing
feelings. There was a high correlation between these two scales (r = .68). Cronbach
alpha for the twelve item DIDF scale was α = .88.
Psychological Flexibility was measured using The Acceptance and Action
Questionnaire II (AAQ-II; Bond, et al., 2011). The AAQ-II measures the tendency to
control thoughts and feelings and ability to act in the presence of difficult thoughts or
feelings. It is the most well-established measure of psychological flexibility, measuring
the totality of the above processes (Gloster, et al., 2011; Luoma, et al., 2011). Each item
is rated on a 7-point Likert scale (e.g., ‘‘I worry about not being able to control my
worries and feelings’’ and ‘‘My painful memories prevent me from having a fulfilling
life”). Higher scores indicate higher PF. The AAQ-II has been shown to have adequate
test-retest reliability, discriminant, convergent and predictive validity (Bond, et al.,
2011; Gloster, et al., 2011). In the present study Cronbach alpha for the scale was α =
.91.
Mental health outcome variables
The Medical Outcomes Study Short Form Health Survey (SF-12) is a widely
used measure of health related quality of life (QOL) that is well validated in Australia
(Andrews, 2002; Sanderson & Andrews, 2002). Two summary scales of physical (PCS)
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and mental (MCS) well-being are generated using the brief integer scoring method
developed by Andrews (2002).
The Depression Anxiety Stress Scale (DASS-21; Lovibond & Lovibond, 1995)
measures depression, anxiety and stress. Items such as, “I felt scared without any good
reason”, are rated on a 4-point Likert scale. The measure has been used with general,
clinical and HIV-infected populations and has good internal consistency, validity and
test-retest reliability (Henry & Crawford, 2005; Lovibond & Lovibond, 1995). In the
present study Cronbach alpha for the depression scale was α = .94, anxiety scale α = .88
and stress scale α = .92.
4.3.3 Procedures
The medical aspects of the screening study began with a sexual health research
nurse conducting a detailed history of sexual and anal health, and giving instructions
regarding the self collection of swabs for anal cytology and anal bacterial sexually
transmitted infections. The cytology results were delivered by phone or mail two weeks
later. Further investigation by high resolution anoscopy (HRA) was offered to
participants whose cytology results were; High Grade Squamous Intraepithelial Lesion
(HSIL), Atypical Squamous Cells-Cannot exclude HSIL (ASC-H), or Atypical
Squamous Cells - Unknown Significance (ASC-US). The HRA procedure is similar to
colposcopy investigation of cervical smear abnormalities. The wait for this procedure
was 8-10 weeks. Approximately two weeks following the HRA procedure, histology
results were given in person or by mail, and follow-up options discussed.
The psychological impact assessments occurred at the three stages of the
medical process outlined above. Data were collected at baseline with questionnaire pack
one given at the initial interview, to be completed that day and mailed back. The second
and third questionnaire packs were mailed in the week following the date the participant
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received their cytology and histology results, approximately two weeks and 12-14
weeks after baseline. Participants not offered an HRA were sent the third questionnaire
pack at a time matched interval of 12 weeks after baseline. The questionnaire packs
took 20-30 minutes to complete.
4.3.4 Statistical Analyses
Data from baseline and the third questionnaire, given after histology results or the time
matched interval were used in this analysis, and are referred to as Time 1 and Time 2.
We did not use questionnaire pack two as this was collected for the medical aspect of
the study, the time frame was only a week and, for this research question we were
interested in examining change over a longer time period. All analyses were completed
using SPSS version 17 for Windows (SPSS Inc, Chicago, Illinois) and Amos version 6
(Amos Development Corporation, Chicago, Illinois).
4.4 RESULTS
Two hundred and ninety one men were approached and 271 (93 %) agreed to
participate in the psychological impact study. Sixty nine percent (187/271) completed
both Time 1 and Time 2; the data from full “Completers” was used in the demographics
and descriptive analysis. Seventy one (26%) completed only baseline but not follow- up
assessments and 13 (5%) dropped out of the medical study. In order to use all available
data to test the models, we utilised expected likelihood imputation to replace missing
values. This method tends to produce unbiased estimates (Howell, 2008).
4.4.1 Descriptive Statistics
Missing value analysis revealed two significant differences between those who
completed every wave of the study (“Completers”) and those who did not complete
every wave (“Non completers”). There was a significant age difference between
Completers (M = 51 years, SD = 9) and Non completers (M = 48 years, SD = 10), F (1,
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289) = 9.34, p = .002. The Completers also scored higher on the AAQ-II (M = 42.88,
SD = 11.35) than Non completers (M = 39.07, SD = 12.45), F (1, 268) = 6.11, p = .014,
showing they were slightly more psychologically flexible.
Completers had a mean age of 51 years (SD = 9, range = 28-73 years), half
(49%) were in an ongoing relationship and of those 76% had been in that relationship
for longer than 5 years. Tertiary education was finished by 64% and 51% were in full
time employment. Nine percent were taking antidepressant medication, 29% were
current smokers, 85% were current alcohol drinkers and 49% had used illicit drugs in
the last 2 years. Fifteen years was the average time since diagnosis of HIV infection (SD
= 8, range = 1-28), 91% were taking HIV medications, with an average of 10 years on
medications (SD = 6, range = 1-22). Mean mental health scores are shown in Table 4.1;
these were calculated on the sum scores for the DASS and SF-12.
According to the study protocol, the cytology (swab) results indicated that 67%
were told after Time 1 that they did not require further investigation by HRA (Low
Threat Group; LTG n=126). The remaining 33% were recommended to have an HRA.
At HRA, 43% either did not need a biopsy or histological results indicated wart virus or
low grade anal intraepithelial neoplasia. These participants form the Reassured Group
(RG n=26), because their cytology results indicated the need for further assessment, but
the second, more detailed assessment indicated low risk for cancer. The remaining 57%
had high grade anal intraepithelial neoplasia histology results, that is, the precursor to
anal cancer and thus form the High Threat Group (HTG n=35).
4.4.2 Main Analysis
To test the situation effect model, one way ANOVAs and analysis of mental health
scores were used to investigate the differences between the medical result groups: low
threat, reassured and high threat. There were no significant differences at Time 1 or 2
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between the groups for ratings of depression, anxiety, stress and physical quality of life,
ps > .05. For example, depression Time 1 LTG M = .51, SD = .63, RG M = .56, SD =
.77, HTG M= .55, SD = .73.
The interaction effect model was tested using repeated measure ANCOVAs
with Time (x2) as the repeated measure, group (LTG, RG, HTG) as the between subject
measure, PF or DIDF as the covariate, and the interactions involving the covariate.
Results showed that neither group nor the interaction between group and PF or DIDF
predicted levels of mental health at Time 2, p > .05. Post hoc power analysis revealed
that assuming the observed small differences were true effects; we would have only had
0.3 or less power to detect it. Thus, the situational and interaction effects models were
not supported.
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Table 4.1 Means and Correlations of Outcome Measures with Proposed mediators
at Time 1 and 2.
Correlations
Measure &

M

SD

DIDF

PF

Time 1

3.24

4.34

.54**

-.64**

Time 2

3.55

4.64

.58**

-.55**

Time 1

2.13

3.36

.51**

-.55**

Time 2

2.59

3.80

.49**

-.43**

Time 1

4.37

4.28

.52**

-.59**

Time 2

4.54

4.53

.57**

-.54**

Time 1

48.62

11.10

.54**

.67**

Time 2

48.38

11.54

.55**

.62**

Time 1

49.60

9.66

-.30**

.22*

Time 2

48.95

9.70

-.35**

.25**

Partial Correlations
Controlling for Time 1
DIDF

PF

.32**

-.13*

.27**

-.07

.35**

-.19*

-.21**

.18*

-.23**

.12*

time
Depression

Anxiety

Stress

Mental
QOL

Physical
QOL

Paired t tests showed no significant effects over time. *p<.05; **p< .001; N= 187; DIDF
= Difficulty Identifying and Describing Feelings; PF = Psychological Flexibility; QOL=
Quality of Life
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The resilience model was tested using multiple regression to evaluate the effect
of baseline levels of PF and DIDF on mental health. Prior to conducting these
regression analyses, we completed a series of correlations and partial correlations to
characterise relationships among the mental health and proposed mediator variables,
shown in Table 4.1. All correlations were significant at p < .05, and ranged from r = .64 to r = .67. The partial correlations controlling for Time 1 level of mental health were
all significant for DIDF and except for anxiety were also significant for PF at p< .05.
The correlation between DIDF and PF was r = -.69, p < .001. The correlations between
the mental health outcome variables are shown in Table 4.2.

Table 4.2 Correlations among the Mental Health Outcome Variables at Time 1.
Depression

Anxiety

Anxiety

.66**

Stress

.71**

.75**

Physical QOL

-.31**

-.27**

Stress

-.17**

** p< .005; QOL= Quality of Life

Hierarchical multiple regression examined the resilience model, the ability of PF
and DIDF at Time 1 to predict mental health at Time 2 when controlling for Time 1
mental health. In each equation mental health at Time 1 was entered first with PF and
DIDF entered simultaneously in the next step. The results are shown in Table 4.3. Each
of the five regressions was consistent. As expected, Time 1 mental health levels
significantly predicted Time 2 mental health, accounting for 20% to 41% of the
variance. This left smaller increments of residual change to be explained by other
variables. Nevertheless, DIDF significantly predicted variance in depression 7%,
anxiety 6%, stress 10%, mental QOL 3% and physical QOL 3%. Relative to those high
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in DIDF with a particular baseline in mental health, those low in DIDF with the same
baseline were less depressed, anxious, stressed and had higher mental and physical QOL
at Time 2. PF did not explain any unique variance over and above DIDF. We assessed
the following demographic and potential confound variables: age, alcohol usage,
average time since diagnosis of HIV infection, level of education, and current immune
system level. None of these variables were significantly related to our mental health
variables, ps > .4, and covarying for them did not alter any of our longitudinal findings.
Mediation analysis then compared the two mediation models. Model 1 assumed
that DIDF was the mediator and Model 2 assumed that PF was the mediator (Figure
4.1). Five tests were run in each model with the different dependent variables
(depression, anxiety, stress, mental and physical QOL). We used a nonparametric
bootstrapping approach to estimate the indirect, meditational effects. This method is
appropriate with smaller samples and does not assume a normal distribution as outlined
in Gaudiano, Herbert and Hayes (2010). From the original dataset, 5,000 identically
sized datasets were created by randomly drawing participants and replacing each value
as it was sampled. The bias corrected 95% confidence intervals (CI) were then
examined. Mediation was declared to be significant if the CI did not contain 0.
.
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Table 4.3 Multiple Regression Analysis Predicting Mental Health at Time 2 (T2)
from Difficulty Identifying and Describing Feelings, Psychological Flexibility and
Mental Health at Time 1 (T1).
Step and variable

R2

ΔR2

ß

Depression T2
1.

Depression T1

.34

.34

.61***

2.

DIDF

.44

.07

.34***

2.

Psychological Flexibility

-.07

Anxiety T2
1.

Anxiety T1

.25

.25

.50***

2.

DIDF

.32

.06

.36***

2.

Psychological Flexibility

-.15

Stress T2
1.

Stress T1

.20

.20

.44***

2.

DIDF

.29

.10

.38***

2.

Psychological Flexibility

-.04

Mental QOL T2
1.

Mental QOL T1

.38

.38

.61***

2.

DIDF

.41

.03

-.16*

2.

Psychological Flexibility

-.10

Physical QOL T2
1.

Physical QOL T1

.41

.41

.64***

2.

DIDF

.45

.03

-.22**

2.

Psychological Flexibility

.06

*p<.01; **p<.005; ***p< .001; N= 176; DIDF = Difficulty Identifying and Describing
Feelings, QOL= Quality of Life
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Model 1: Does DIDF mediate the effect of PF on Depression?
DIDF

A
PF
(Dep T1)

B
Depression T2

C'

Model 2: Does PF mediate the effect of DIDF on Depression?
A

PF

DIDF
(Dep T1)

B
Depression T2

C'

Figure 4.1 Mediation Models
PF= Psychological Flexibility; DIDF= Difficulty Identifying and Describing Feelings;
A=Direct effect; B=Direct effect; C'=Direct effect; Dep T1= Controlling for Time 1
level of Depression
NB: For mediation to occur: B= Significant (shown in Table 4.3), C'= Non Significant
(shown in Table 4.3), AxB (Indirect effect) = Significant (shown in Table 4.4).
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The mediation results shown in Table 4.4, give clear evidence that PF is being
mediated by DIDF. That is, there were reliable indirect effects between PF and mental
health via DIDF. None of the direct effects between PF and mental health were
significant when DIDF was entered in the model (see, e.g., Table 4.3), suggesting that
DIDF fully mediated the relationship between PF and mental health. We tested the
reverse model (DIDF leading to PF) and found no evidence for an indirect effect (Table
4.4). These analyses are consistent with DIDF, rather than PF, being the mediator. DIDF
fully mediated the relationship between PF and each mental health measure. Participants
who indicated high levels of PF were more likely to have low levels of DIDF, and
through low levels of DIDF, less likely to have worse mental health (e.g. depression).
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Table 4.4 Mediation Effects of Psychological Flexibility and Difficulty Identifying
and Describing Feelings on Time 2 Mental Health, using Time 1 Mental Health as
a covariate.
Model 1

Model 2

Psychological Flexibility 

Difficulty Identifying and

Difficulty Identifying and

Describing Feelings 

Describing Feelings

Psychological Flexibility

Indirect
effect^

BC 95% CI

Point
Variable

Estimate

Indirect
effect^^

BC 95% CI

Point
Lower

Upper

Mean

Estimate

Lower

Upper

Mean

Depression

.249*

.144

.354

-.052

-.138

.044

Anxiety

.263*

.150

.397

-.105

-.216

.005

Stress

.280*

.164

.393

-.025

-.146

.090

-.112*

-.223

-.008

-.066

-.192

.056

-.167*

-.260

-.081

.042

-.065

.142

Mental
QOL
Physical
QOL

*p<.05; BC CI= Bias corrected and accelerated Confidence Interval; QOL= Quality of
Life; Time 1 measures controlled in all analyses. ^ The indirect effect (AxB in Figure
4.1) of psychological flexibility through emotional awareness on mental health. ^^The
indirect effect (AxB in Figure 4.1) of difficulty identifying and describing feelings
through psychological flexibility on mental health.
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4.5 DISCUSSION
We examined the influence of DIDF and PF on men with HIV undergoing anal
cancer screening. Three models of influence were proposed. Neither the situational or
interaction model were supported, in that greater health threat did not predict changes in
mental health, nor did DIDF and PF reduce the impact of threat on mental health. The
resilience model had consistent support. Generally, people who had low DIDF and high
PF at Time 1, tended to experience increases in mental health at Time 2, relative to
those with high DIDF and low PF at Time 1 and the same baseline level of mental
health. DIDF had a direct effect on mental health change, whereas PF had a significant
indirect effect through DIDF.
Our results show that lower DIDF predicted less depression, anxiety and stress
and higher levels of mental and physical QOL. This is consistent with other studies
showing emotion related skills are protective against a variety of poor psychological
outcomes (e.g., see Kashdan & Rottenberg’s, (2010) review of psychological
flexibility). More specifically, when DIDF was high, past research suggests that patients
with dermatitis had lower global assessment of functioning scores (Picardi, et al., 2007),
medical students and their confederates had higher psychological distress (Berrocal, et
al., 2009) and undergraduate students in both a cross sectional and 3 week diary study
displayed greater anxiety symptoms and diminished psychological functioning
(Kashdan, Barrios, Forsyth, & Steger, 2006). A longitudinal study of males from the
general population in Finland showed higher mental and physical QOL when
alexithymia was lower (Saharinen, et al., 2008).
PF has shown cross-sectional and longitudinal links to mental health (Berrocal,
et al., 2009; Bond & Bunce, 2003; Donaldson-Feilder & Bond, 2004; Hayes, et al.,
2006; Karekla & Panayiotou, 2011; McCracken & Zhao-O'Brien, 2010; Wicksell,

Page | 76

Renöfält, Olsson, Bond, & Melin, 2008). We replicated this finding in the present study.
However, unlike past studies, we included a measure of the ability to identify and
describe feelings. We found that the link between PF and mental health is entirely
mediated by DIDF in this medical screening context. Research by Baer and colleagues
(Baer, Lykins, & Peters, 2012; Baer et al., 2008) in the area of mindfulness has shown
similar patterns. Long term meditators had increased skills in describing feelings which
mediated their increase in psychological well-being.
These results need to be viewed with caution as we used self report rather than
ecologically salient emotional recording. Measuring the predictor variables and
mediators at the same time limited our ability to determine whether PF enhances DIDF
or DIDF enhances PF. We found no evidence that the medical test results impacted on
general mental health which was the focus of the present study; however there was a
difference in cancer related worry and ratings of anal and future health. These findings
were examined in more detail in Chapter 3, Landstra et al. (2012). Our participants may
have handled the process more easily due to being accustomed to regular health checks
as a function of having HIV. Nevertheless the prospective longitudinal nature of this
study extends previous research by suggesting that the ability to identify and describe
feelings and PF helps men with HIV to experience positive changes in mental health
over time. It may be that being more psychologically flexible is an antecedent to
promoting the ability to identify and differentiate the nuances of pleasant and unpleasant
emotions which in turn enhances an individual’s mental health. Studies have shown
men may be particularly vulnerable to poor adjustment to stressful life events because
they are thought to have more difficulties identifying and describing emotions and lower
PF than women (Karekla & Panayiotou, 2011; Mattila, et al., 2008). A study of men
infected with HIV (Lumley, et al., 1997) found that, while disease severity was not

Page | 77

impacted, symptom reports and illness behaviours were greater in men with higher
DIDF.
This study has shown that both DIDF and PF are important and appear to
promote mental health in a group of men with HIV. More research is needed to
understand the links between PF and DIDF. For example, using ACT to experimentally
increase PF, and assessing whether the ability to identify and describe feelings
subsequently improves; and conversely to improve the identification and description of
feelings to see if this leads to improvements in PF. The present results suggest the
former and not the latter will be the best model.
These results have important implications for the many health screening
programs now available. While screening programs can prevent disease, small adverse
effects on the majority of those screened could impact general public health (StewartBrown & Farmer, 1997). Using measures of PF and emotion identification/description
to identify participants low in these abilities may assist to triage those who need the
offer of extra support aimed at assisting them to process the emotions arising from their
health condition (van Middendorp, et al., 2008). ACT interventions may be well suited
as the review of ACT therapies by Ruiz (2010) notes, “extremely short interventions”
have been efficacious.

Page | 78

CHAPTER FIVE
CONCLUSIONS AND FUTURE DIRECTIONS
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5.1 SUMMARY
This thesis set out to investigate the psychological impact of anal cancer
screening. The review of prior research showed that anal cancer screening is recognised
as an important cancer prevention tool in high prevalence populations. However, there
is a lack of knowledge about the psychological impact of the screening process. This
study has advanced the area by assessing the psychological impact of a two stage
screening program for HIV-infected men who have sex with men. The participants
completed questionnaires at 3 time points in the screening process which assessed their
general mental health and psychological impact from the particular screening procedure.
It was found that test specific psychological questionnaires (TSPQ), which measure the
direct impact of the procedure and receipt of results, revealed increased levels of worry,
poorer ratings of anal health and optimism for future health amongst those
recommended to have further testing by high resolution anoscopy (HRA). Level of
worry and optimism for future health was significantly different between those who
received worse medical results than others who were given reassuring results after the
HRA testing. Furthermore, those who had the HRA test were more optimistic about
their future health after receiving the reassuring results than the participants who did not
have the HRA test. We have proposed that this reassurance may lead to or be an
indicator of ‘unrealistic optimism’ which in turn may lead to perceptions that returning
for subsequent testing is not needed. There is still debate about the optimal frequency of
follow-up screening and treatment procedures for pre-cancer results (Jin, et al., 2011),
but any reluctance to seek future tests may be problematic. Similar to other cancer
screening studies (McNaughton-Collins, Fowler, et al., 2004; Pickles, et al., 2007), the
results showed that general psychological questionnaires (GPQ), which measure mental
health in the last 1-2 weeks, do not capture any changes in mental health outcomes
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related to the procedure and results. Screening programs need to triage effectively those
who may need additional support and provide sufficient support and education to those
participants to ensure adequate follow-up and monitoring of high grade pre-cancerous
disease.
Each person will respond to situations differently based on a variety of factors
including their history of cancer, support systems, previous symptoms and individual
characteristics. This research was particularly focussed on increasing the understanding
of the characteristics of difficulty identifying and describing feelings (DIDF) and
psychological flexibility (PF). We found no support for our second hypothesis, in that
the levels of DIDF and PF did not ameliorate responses to worse medical results. There
were no differences in responses to more adverse medical results in men with less PF
and more DIDF. The data showed support for the third hypothesis; participants who
had more PF and less DIDF had better mental health over the time period of the
screening process, irrespective of medical outcome. Lower levels of DIDF predicted
less depression, anxiety and stress and higher levels of mental and physical quality of
life, controlling for time 1 levels of mental health. Mediation analysis showed the level
of DIDF fully mediated the relationship between PF and mental health. Those with high
PF were likely to have low levels of DIDF and through low levels of DIDF tended to
have better mental health. Enhancing these characteristics may provide a way to assist
screening participants to cope better.
5.2 LIMITATIONS
The research had some general limitations that have implications for future
research. Exclusive use of self-report measures at limited time periods is a limitation
that could be overcome by use of ecological momentary assessment sampling of
emotions with smart phone apps (Kashdan, et al., 2010). This allows capture of real
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time assessment at repeated time points over the days following each procedure and can
capture sensitivity to context. This type of sampling provides a rich source of data, has
been found to be acceptable to participants and to show individual differences
(Kashdan, et al., 2010). This richer source of data over more time points would give an
indication of the time period of emotional impact from the results. This would be useful
in optimising the timing and establishing of support for participants who need it.
The baseline measurement was taken after the medical interview and initial
swab sampling. A more stringent baseline would ideally occur prior to those processes.
This was not possible as the informed consent process occurred at the same time as the
swab sampling and we were not able to access the participants until this had been
completed. Adding a fourth time point, six months after the study began would have
enabled us to measure how long the screening process and results were causing
increased cancer-specific worry. Consequently, we are unable to say how long worry
persisted for those with high grade medical results.
Measuring PF and DIDF at the same time point limited our ability to explore the
relationship between the two. We could not show which precedes which or whether they
are co-occurring. There is a need for further studies to address some of these
methodological issues, some possibilities are outlined below.
5.3 FUTURE DIRECTIONS
This study was one of the first to investigate the psychological impact of anal cancer
screening in HIV-infected men. While our cancer-specific worry results are somewhat
similar to the single other study published (Tinmouth, et al., 2011), there were different
medical processes, time points and questionnaires used, and therefore a direct
comparison is limited. Our study showed that using test specific questionnaires better
captures potential psychological impacts and that having a two stage medical process
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creates worry in those who need to return for the second screening. Further research is
needed to confirm these results in other groups of HIV-infected men, particularly as our
population was mostly middle aged, working Caucasian men. There is also a need to
investigate the psychological impact of anal cancer screening in other at risk
populations such as women with prior HPV related cervical disease, HIV-infected
women and HIV negative MSM who are also high risk and are being targeted for
screening. In particular, the HIV negative MSM population may not be as familiar with
having regular medical testing as this study’s sample and this may lead to them being
more emotionally vulnerable to the screening process. Research with the addition of a 6
month follow-up in order to ascertain whether the worry shown by some men dissipates
would also be valuable.
Investigating the psychological impact is only the initial stage of research in this
area. Where there is a detrimental impact, even small effects experienced by a minority
of participants can impact preventative behaviours, risk taking and increase a passive
approach to health care (Stewart-Brown & Farmer, 1997). Those receiving reassuring
results may be at most risk of decreasing their protective behaviours (Larsen, et al.,
2007). Therefore, there is great scope for research into the types of supports needed to
cope with the psychological impact of the screening process and results. Research in
cervical screening has shown the benefit of clear written and verbal communication in
participant’s having a better understanding of what results mean, less anxiety and better
attendance for follow-up procedures (Wilkinson, et al., 1990; Wilson & Hines, 2000).
Some of the questions that could be addressed are: what are the most effective styles of
support (e.g., printed pamphlets, internet resources or support workers on the telephone
or in person)? How much support is needed and when is it best provided? Furthermore,
is there use for a TSPQ such as a distress thermometer or psychological flexibility
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screen to triage those who need extra support? And, there is scope to test the validity of
the stepped care approached outlined in chapter 2. Exploring the role of PF and DIDF in
screening for other forms of cancer (e.g., breast) might also be useful.
We did not measure any changes in illness behaviour or medical safety
behaviours which have been shown to increase in prostate and breast screening
participants (Brett, et al., 2005; Fowler, et al., 2006). Changes in sexual behaviour and
related emotional responses such as shame, embarrassment and self-stigma may also be
an area of interest. Measuring these emotions and behaviours would assist in knowing
the full impact of the screening process.
The longitudinal nature of this study provided an opportunity to investigate the
impact of PF and DIDF on mental health. As previous research had shown these
characteristics are related to each other (Berrocal, et al., 2009), we extended this finding
by showing that PF’s impact on mental health is mediated by DIDF. An important
direction for future research would be to experimentally enhance DIDF and PF
alternately to see the impact on the other. It is unclear from our research whether the
ability to identify and describe feelings is enhanced by having greater PF or whether PF
is enhanced by having a greater ability to identify and describe one’s feelings.
Acceptance and Commitment Therapy (ACT) interventions offer the opportunity to
provide brief interventions which could enhance participant’s ability to cope with the
screening process and the worry that can be created. Trialling a brief ACT intervention
in a screening program could provide a cost effective method of supporting participants
in screening programs.
5.4 CONCLUSIONS
This thesis has addressed the lack of investigation into the psychological impact
of a two stage anal cancer screening program in HIV-infected men. Additionally, this
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study is the first to investigate the longitudinal impact of psychological flexibility and
difficulty identifying and describing feelings on mental health. The results demonstrate
that there is a psychological impact when test specific psychological questionnaires are
used and that general psychological questionnaires do not capture change in this
population undergoing this screening process. Those with greater PF or less DIDF
showed better mental health over the screening time period and the results showed that
the impact of PF on mental health was mediated by the level of DIDF. Further studies in
both these areas are necessary to confirm these results and progress the research field to
interventions and experimental studies. These results are important because anal cancer
screening will become more prevalent and clinics offering this may need to use TSPQ to
triage those who will need support. Providing a brief intervention targeting the ability to
identify and describe feelings or enhancing psychological flexibility could benefit
patients who may need extra support to cope with the screening process.
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APPENDIX ONE
Participant Flow Chart
Eligible
n=471
Declined
Consent
n=180

Baseline

Recruited n=291
Consent, interview,
swab & blood test

Declined Questionnaire
n=4

Completed n=271
Response Rate 94%

Did not complete
n=16
Cytology Result
Negative & LSIL n=179
Declined
Questionnaire
n=1
Did not
complete
n=29

Unsatisfactory Swab
n=6
Declined Repeat Swab
n=5
Unable to collect n=1

Questionnaire
Two n=178

Cytology Result
ASCUS, ASC-H & HSIL n=86
Declined
Questionnaire
n=1

No Medical Follow up
Questionnaire Three
n=138

Time 2

Questionnaire Two
n=85

Did not
complete
n=14

Completed n=149
Response Rate 84%

HRA completed off
protocol n=11

LSIL= Low Grade Squamous Intraepithelial Lesion;
HSIL = High Grade Squamous Intraepithelial Lesion;
ASC-US = Atypical Squamous Cells: Unknown Significance;
ASC-H = Atypical Squamous Cells: Cannot exclude HSIL;
HRA= High Resolution Anoscopy;
HGAIN = High Grade Anal Intraepithelial Neoplasia

Questionnaire One
n=287

Declined
HRA n=5

Completed n=71
Response Rate 84%

Histology Results
No Biopsy, Negative, LSIL,
Wart Virus & Other n=28
Declined
Questionnaire n=1
Did not
complete
n=25

Completed n=113
Response Rate 82%

Did not
complete
n=5

Time 3

HRA Procedure n=66
Histology Results received 2 weeks later

Questionnaire
Three n=27

Histology Results
HGAIN n=38
Decline
Questionnaire
n=2

Completed n=22
Response Rate 81%

Questionnaire Three
n=36

Did not
complete
n=8

Completed n=28
Response Rate 78%

APPENDIX TWO
Measures used in Questionnaire Packs.
Measures administered at each time point
Measure*
Distress Thermometer
Anal Screening Questionnaire (ASQ)
Depression, Anxiety Stress Scale 21 (DASS-21)
Medical Outcomes Short Form 12 (SF-12)
Toronto Alexithymia Scale 20 (TAS-20)
Acceptance and Action Questionnaire II (AAQ-II)
* Listed in the order given.

Baseline
X
X
X
X
X
X

Time 2
X
X
X
X

Time 3
X
X
X
X
X

Distress Thermometer
Please circle the number 0-10 that best describes how much distress you experienced:
Taking the swab
10

Extreme distress

9
8
7
6
5
4
3
2
1
0

No distress
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ASQ
We would like to know how you have been feeling since your anal swab this week.
Please circle the response which most closely applies to you.
Since my anal swab I feel:
In good general health

Better than
usual

Same as
usual

Worse than
usual

Much worse
than usual

Happy about the way my
body feels

Better than
usual

Same as
usual

Worse than
usual

Much worse
than usual

In control of my body

Better than
usual

Same as
usual

Worse than
usual

Much worse
than usual

In good anal health

Better than
usual

Same as
usual

Worse than
usual

Much worse
than usual

Optimistic about my future
health

Better than
usual

Same as
usual

Worse than
usual

Much worse
than usual

Interested in sex

Not at all

No more
than
usual

Rather more
than usual

Much more
than usual

How much have you thought
about anal cancer?

A lot

Some

Only a little

Not at all

How often has the possibility
that you might develop anal
cancer worried you?
How much of the time have
you worried about dying
soon?
What do you think is your
chance of getting anal cancer
some day?

A lot

Some

Only a little

Not at all

A lot

Some

Only a little

Not at all

In the past month:

Much
more
than
average

A little
more
than
average

Same as
average

A little
less than
average

Much
less than
average

DASS
Please read each statement and circle a number 0, 1, 2 or 3, which indicates how much
the statement applied to you over the past week. There are no right or wrong answers.
Do not spend too much time on any statement.
The rating scale is as follows:
0
Did not apply to me at all
1
Applied to me to some degree, or some of the time.
2
Applied to me to a considerable degree, or a good part of the time.
3
Applied to me very much, or most of the time.
I found it hard to wind down
I was aware of dryness of my mouth
I couldn’t seem to experience any positive feeling at all
I experienced breathing difficulty (e.g., excessively rapid
breathing, breathlessness in the absence of physical exertion)
I found it difficult to work up the initiative to do things
I tended to over-react to situations
I experienced trembling (e.g., in the hands)
I felt that I was using a lot of nervous energy
I was worried about situations in which I might panic and make
a fool of myself
I felt that I had nothing to look forward to
I found myself getting agitated
I found it difficult to relax
I felt down-hearted and blue
I was intolerant of anything that kept me from getting on with
what I was doing
I felt I was close to panic
I was unable to become enthusiastic about anything
I felt I wasn’t worth much as a person
I felt that I was rather touchy
I was aware of the action of my heart in the absence of physical
exertion (e.g., sense of heart rate increase, heart missing a beat)
I felt scared without any good reason
I felt that life was meaningless

0
0
0
0

1
1
1
1

2
2
2
2

3
3
3
3

0
0
0
0
0

1
1
1
1
1

2
2
2
2
2

3
3
3
3
3

0
0
0
0
0

1
1
1
1
1

2
2
2
2
2

3
3
3
3
3

0
0
0
0
0

1
1
1
1
1

2
2
2
2
2

3
3
3
3
3

0
0

1
1

2
2

3
3
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SF-12 HEALTH SURVEY FORM
INSTRUCTIONS: This survey asks for your views about your health. This
information will help keep track of how you feel and how well you are able to do your
usual activities.
Answer every question by marking one box. If you are unsure about how to
answer a question, please give the best answer you can.
1. In general, would you say your health is:
Excellent

Very good

Good

Fair

Poor

The following items are about activities you might do during a typical day. Does your
health now limit you in these activities? If so, how much?
ACTIVITIES

2. Moderate activities, such as moving a table,
pushing a vacuum cleaner, bowling, or playing golf
3. Climbing several flights of stairs

Yes,
Yes,
No,
Limited Limited Not
A Lot
A Little Limited
At All









During the past week, have you had any of the following problems with your work or
other regular daily activities as a result of your physical health?
4. Accomplished less than you would like

YES


NO


5. Were limited in the kind of work or other activities





During the past week, have you had any of the following problems with your work or
other regular daily activities as a result of any emotional problems (such as feeling
depressed or anxious)?
6. Accomplished less than you would like

YES


NO


7. Didn't do work or other activities as carefully as usual





8. During the past week, how much did pain interfere with your normal work, include
both outside the home and housework?
Not at all

A little bit

Moderately

Quite a bit

Extremely

These questions are about how you feel and how things have been with you during
the past week.
For each question, please give ONE answer that comes closest to the way you have been
feeling. How much of the time during the past week –

9. Have you felt calm and
peaceful?
10. Did you have a lot of
energy?
11. Have you felt
downhearted and blue?

All of
the
time

Most
of the
time


A Good
Bit of
the
time











Some
of the
Time


A
Little
of the
Time


None
of the
Time


















12. During the past week, how much of the time has your physical health or emotional
problems interfered with your social activities, like visiting with friends, relatives, etc.?
All of the time

Most of the
time

Some of the
time

A little of the
time

None of the
time
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TAS
Using the scale provided as a guide, indicate how much you agree or disagree with each
of the following statements by choosing the appropriate number. Give only one answer
for each statement.
Neither
Strongly Moderately Disagree Moderately Strongly
Disagree Disagree nor
Agree
Agree
Agree
I am often confused about what
1
emotion I am feeling
It is difficult for me to find the right
1
words for my feelings
I have physical sensations that even
1
doctors don't understand
I am able to describe my feelings
1
easily
I prefer to analyse problems rather
1
than just describe them
When I am upset, I don't know if I
1
am sad, frightened, or angry
I am often puzzled by sensations in
1
my body
I prefer to just let things happen
rather than to understand why they 1
turned out that way
I have feelings that I can't quite
1
identify
Being in touch with emotions is
1
essential
I find it hard to describe how I feel
1
about people
People tell me to describe my
1
feelings more
I don't know what's going on inside
1
me

2

3

4

5

2

3

4

5

2

3

4

5

2

3

4

5

2

3

4

5

2

3

4

5

2

3

4

5

2

3

4

5

2

3

4

5

2

3

4

5

2

3

4

5

2

3

4

5

2

3

4

5

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

I often don't know why I am angry 1
I prefer talking to people about
their daily activities rather than
their feelings
I prefer to watch ‘light”
entertainment shows rather than
psychological dramas
It is difficult for me to reveal my
innermost feelings, even to close
friends
I can feel close to someone even in
moments of silence

I find examination of my feelings
1
useful in solving personal problems
Looking for hidden meanings in
movies or plays distracts from their 1
enjoyment

2

3

4

5

2

3

4

5
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AAQ
Below you will find a list of statements. Please rate how true each statement is for you
by circling a number next to it. Use the scale below to make your choice.
1

2

3

4

5

6

7

never
true

Very
seldom
true

seldom
true

almost
sometimes frequently
always
true
true
true

always
true

It’s OK if I remember something unpleasant.

1

2

3

4

5

6

7

My painful experiences and memories make it difficult for
me to live a life that I would value.

1

2

3

4

5

6

7

I’m afraid of my feelings.

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

I am in control of my life.

1

2

3

4

5

6

7

Emotions cause problems in my life.

1

2

3

4

5

6

7

It seems like most people are handling their lives better
than I am.

1

2

3

4

5

6

7

Worries get in the way of my success.

1

2

3

4

5

6

7

My thoughts and feelings do not get in the way of how I
want to live my life.

1

2

3

4

5

6

7

I worry about not being able to control my worries and
feelings.
My painful memories prevent me from having a fulfilling
life.

Distress Thermometer for Time 2
Distress Thermometer
Please circle the number 0-10 that best describes how much distress you experienced:
Waiting for the swab
results
10

Extreme distress

9
8
7
6
5
4
3
2
1
0

No distress
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Distress Thermometer for Time 3 HRA Group

Distress Thermometer
Please circle the number 0-10 that best describes how much distress you experienced in
relation to the “HRA” procedure with Dr Hillman:

During the “HRA”

Waiting for the “HRA”

Since the “HRA”

procedure

results

Results

10

Extreme distress

10

Extreme distress

10

9

9

9

8

8

8

7

7

7

6

6

6

5

5

5

4

4

4

3

3

3

2

2

2

1

1

1

0

No distress

0

No distress

0

Extreme distress

No distress

Distress Thermometer for Time 3 Control Group

Distress Thermometer
Please circle the number 0-10 that best describes how much distress you experienced:

In the last week
10

Extreme distress

9
8
7
6
5
4
3
2
1
0

No distress
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APPENDIX THREE
Participant Information and Consent Form

ST. VINCENT’S HOSPITAL SYDNEY LIMITED /
UNIVERSITY OF NEW SOUTH WALES

PARTICIPANT INFORMATION SHEET AND CONSENT FORM
Blokes with Anal Squamous Intra-epithelial Lesions (BASIL)
Validation of the acceptability and reliability of anal swabs used for cytological
screening to detect Anal Squamous Intra-epithelial Lesions (ASIL) in HIV-positive Men
who have Sex with Men (MSM)

Invitation
You are invited to participate in a research study into the causes and progression of
lesions in the anus which might lead to anal cancer among HIV-positive gay men.
The study is being conducted by:
Dr Richard Hillman, Senior Lecturer, the University of Sydney and Staff
Specialist at IBAC, St Vincent’s Hospital, Darlinghurst.
Leon Botes, RN, PhD student at the Faculty of Medicine, University of Sydney.
Jodie Butler, Clinical Psychologist, H2M St Vincent’s Hospital, Darlinghurst
Before you decide whether or not you wish to participate in this study, it is
important for you to understand why the research is being done and what it will
involve. Please take the time to read the following information carefully and discuss
it with others if you wish.
1. ‘What is the purpose of this study?’
The purpose is to investigate the high rates of anal cancer among HIV-positive gay
men. The study will investigate the value of self-collected and health care-worker
collected anal swabs for the detection of abnormal cells in the anus. The study will
also follow up any abnormalities detected and give you the opportunity to undergo
further investigations and treatment if required. By looking at the results of all the
tests, and comparing them to factors such as age and HIV status, it is hoped to be
able to better predict who might be at greatest risk of anal cancer.

The medical aspect of this study may have a psychological impact on you. We will
ask you to complete questionnaires relating to how you are functioning
psychologically at three different intervals. This will help us determine if this
screening process does have a psychological impact and whether further
psychosocial support is necessary.
2. ‘Why have I been invited to participate in this study?’
Previous research has indicated that HIV-positive gay men are at greater risk of
developing anal cancer than the general community. You are eligible to participate
in this study because you have identified as being HIV-positive and gay.

3. ‘What if I don’t want to take part in this study, or if I want to withdraw
later?’
Participation in this study is voluntary. It is completely up to you whether or not you
participate. If you decide not to participate, it will not affect the treatment you
receive now or in the future. Whatever your decision, it will not affect your
relationship with the staff caring for you.
New information about the condition being studied may become available during
the course of the study. You will be kept informed of any significant new findings
that may affect your willingness to continue in the study.
If you wish to withdraw from the study once it has started, you can do so at any time
without having to give a reason.
However, it may not be possible to return your samples to you or withdraw your
data from the study results if these have already had your identifying details
removed.
4. ‘What does this study involve?’
If you agree to participate in this study, you will be asked to sign the Participant
Consent Form.
This study will be conducted over 3 years. If you agree to participate in this trial, you
will then be asked to provide the following:









Information concerning your HIV status, such as CD4 count and viral
load (This information will be taken from your medical records)
Information concerning your lifestyle, such as sexual activity and
smoking status
A self-collected anal swab to look for abnormal cells
A second self-collected anal swab to test for sexually transmitted
infections
A urine specimen to test for sexually transmitted infections
A throat swab to test for sexually transmitted infections
A blood specimen to test for sexually transmitted infections
A blood specimen to test for your immune system
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A blood specimen to be stored for possible future immunological,
genetic and genotyping studies
The first Psychological wellbeing questionnaires; which will be available
online or on paper .

We will inform you of all of the results as soon as they are available.
If no abnormal cells are detected on the anal sample, then we will let you know this
and explain the meaning of it to you
If mildly abnormal cells are detected in the anal swab, you will be given the
opportunity to be checked out for warts in and around the anus. It will also be
recommended that you have a repeat anal swab in 6 months.
If significantly abnormal cells are detected in the anal swab, you will be given the
opportunity to see the study doctor, Dr Richard Hillman. He will explain the meaning
of this finding to you and suggest that you may wish to undergo further investigation
using a procedure called High Resolution Anoscopy (HRA). This technique uses a
strong microscope and some special dyes to look inside the anal canal for
abnormalities.
The second psychological wellbeing questionnaire will be sent to you 1 week after
you receive your anal swab results. This will be via post or an email with a web link.
Not all participants will receive this questionnaire. We will send it to all who have
been offered further investigation by HRA and to a comparison group who do not
require further investigation by HRA.
If internal anal abnormalities are seen, the doctor may request to take a small biopsy,
which is usually painless. If the abnormalities are present on the outside of the anus,
then the doctor will recommend the use of a local anaesthetic prior to taking a
biopsy.
The doctor will make arrangements for you to receive the results of your test, usually
within two weeks of the procedure. He will then explain the meaning of these fully to
you. If there are any treatments required, then he will discuss the options available to
you, and what further follow up is recommended.
The third psychological wellbeing questionnaire will be sent to you 1 week after you
receive your HRA results. This will be via post or an email with a web link. All
participants who completed the second questionnaire will be requested to complete
the third, even if you did not have the HRA.

Samples of blood taken from a vein will be required. The amount of blood taken
will be equivalent to 15 of millilitres (or 3 of teaspoons).
In addition, the researchers would like to have access to your medical records to
obtain information relevant to the study.
You will be asked a few questions about where you live (postcode), your smoking
habits, sexual habits, past and present sexually transmitted infections, your CD4
counts and HIV viral loads.
5. ‘How is this study being paid for?’
The study is part of a PhD study undertaken by Leon Botes within the Faculty of
Medicine, the University of Sydney, Leon Botes is funded by a scholarship
administered by the Royal Australasian College of Physicians.
The Novartis scholarship will cover the first year of the clinical researcher’s (Mr
Leon Botes) living expenses.
Second and third year living expenses for the course of the PhD will be self funded
by Mr Botes.
The St Vincent’s Hospital AIN Trust Fund, IBAC, will meet any outstanding costs
regarding the BASIL study.
6. ‘Are there risks to me in taking part in this study?’
All medical procedures involve some risk of injury. In addition, there may be risks
associated with this study that are presently unknown or unforeseeable. In spite of all
reasonable precautions, you might develop medical complications from participating
in this study. The known risks of this study are:




Discomfort while taking the anal swabs
Possible bleeding after swabs have been taken
If a biopsy was needed, bleeding could occur from the rectum or the next
time you go empty your bowels

7. ‘What happens if I suffer injury or complications as a result of the study?’
If you suffer any injuries or complications as a result of this study, you should
contact the study doctor as soon as possible, who will assist you in arranging
appropriate medical treatment.
You may have a right to take legal action to obtain compensation for any injuries or
complications resulting from the study. Compensation may be available if your
injury or complication is caused by the drugs or procedures, or by the negligence of
any of the parties involved in the study. If you receive compensation that includes an
amount for medical expenses, you will be required to pay for your medical treatment
from those compensation monies.
If you are not eligible for compensation for your injury or complication under the
law, but are eligible for Medicare, then you can receive any medical treatment
required for your injury or complication free of charge as a public patient in any
Australian public hospital.
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8. ‘Will I benefit from the study?’
This study aims to further medical knowledge and may improve diagnosis and
prevention of anal cancer and support for people going through the screening
process. However, it may not be directly of benefit to you. Psychological wellbeing
summaries will be given to you after completing the questionnaires.
9. ‘Will taking part in this study cost me anything, and will I be paid?
Participation in this study will not cost you anything and there is no reimbursement
for taking part in the study.
10. ‘What will happen to my tissue sample after it has been used?’
The blood or tissue sample/s you provide during the study will be stored at the
completion of the study. The researchers wish to store (or ‘bank’) the samples, you
will be asked whether you agree to this and, if so, will be asked to sign a specific
consent form.
If you do agree to your tissue samples being stored, they will not be used for other
research projects, except with your written consent or, under some circumstances,
with the approval of a Human Research Ethics Committee at that time.
In the event where further studies, such as genetic studies are performed, the results
will not be linked to your hospital record and will not affect your care or the care of
your family.
11. ‘How will my confidentiality be protected?’
Of the people treating you, only the researchers and IBAC staff will know whether
or not you are participating in this study. Any identifiable information that is
collected about you in connection with this study will remain confidential and will
be disclosed only with your permission, or except as required by law. Only the
researchers named above will have access to your details and results that will be
held securely at St Vincent’s IBAC clinic.
12. ‘What happens with the results?’
If you give us your permission by signing the consent document, we plan to publish
the results in peer-reviewed journals, presentation at conferences and or other
professional, as well as part of a PhD thesis.
In any publication, information will be provided in such a way that you cannot be
identified. Results of the study will be provided to you, if you wish.
13. ‘What happens to my treatment when the study is finished?’
Your treatment as a patient at IBAC will continue as usual. This decision will be
made in consultation between you and your treating doctor about the most
appropriate treatment for you at that time.

14. ‘What should I do if I want to discuss this study further before I decide?’
When you have read this information, the researchers, Leon Botes or Dr Richard
Hillman, will discuss it with you and any queries you may have. If you would like to
know more at any stage, please do not hesitate to contact them on (02) 9845 6276.
15. ‘Who should I contact if I have concerns about the conduct of this study?’
This study has been approved by St Vincent’s Hospital HREC. Any person with
concerns or complaints about the conduct of this study should contact the Executive
Officer in the Research Office who is the person nominated to receive complaints
from research participants. You should contact them on 02 8382 2075 and quote
quote file number 08/049.
The conduct of this study at the IBAC clinic has been authorised by the St Vincent’s
Hospital, Darlinghurst. Any person with concerns or complaints about the conduct
of this study may also contact the Research Governance Officer or St Vincent’s
Hospital Ethics Committee on 02 8382 2075 and quote reference number 08/049svh
Thank you for taking the time to consider this study.
If you wish to take part in it, please sign the attached consent form.
This information sheet is for you to keep.
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ST. VINCENT’S HOSPITAL SYDNEY LIMITED /
UNIVERSITY OF NEW SOUTH WALES
PATIENT INFORMATION STATEMENT AND CONSENT FORM

CONSENT FORM

Blokes with Anal Squamous Intra-epithelial Lesions (BASIL)
Validation of the acceptability and reliability of anal swabs used for cytological
screening, to detect Anal Squamous Intra-epithelial Lesions (ASIL) in HIV-positive
Men who have Sex with Men (MSM)

1.

I,.................................................................................................................
of................................................................................................................
agree to participate as a subject in the study described in the subject information
statement set out above.

2.

I acknowledge that I have read the subject information statement, which explains
why I have been selected, the aims of the study and the nature and the possible
risks of the investigation, and the statement has been explained to me to my
satisfaction.

3.

Before signing this consent form, I have been given the opportunity of asking any
questions relating to any possible physical and mental harm I might suffer as a
result of my participation and I have received satisfactory answers.

4.

I understand that I can withdraw from the study at any time without prejudice to
my relationship to the St Vincent’s Hospital or the University of Sydney.

5.

I agree that research data gathered from the results of the study may be published,
provided that I cannot be identified.

6.

I understand that if I have any questions relating to my participation in this
research, I may contact Dr Richard Hillman on telephone 02 9845 6276, who will
be happy to answer them.

7.

I acknowledge receipt of a copy of this Consent Form and the Subject Information
Statement.
Complaints may be directed to the, Executive Officer, St Vincent’s Hospital
Research Ethics Committee DARLINGHURST 2010 AUSTRALIA (phone 8382
2075, fax 8382 3667, email research@stvincents.com.au).

SIGNATURE OF SUBJECT [OR PERSON RESPONSIBLE]

PLEASE PRINT NAME

DATE

SIGNATURE OF WITNESS

PLEASE PRINT NAME

DATE

SIGNATURE OF INVESTIGATOR
PLEASE PRINT NAME

DATE
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ST. VINCENT’S HOSPITAL SYDNEY LIMITED /
UNIVERSITY OF NEW SOUTH WALES
PATIENT INFORMATION STATEMENT AND CONSENT FORM

Blokes with Anal Squamous Intra-epithelial Lesions
(BASIL)
Validation of the acceptability and reliability of anal swabs used for cytological
screening, to detect Anal Squamous Intra-epithelial Lesions (ASIL) in HIVpositive Men who have Sex with Men (MSM)

I hereby wish to WITHDRAW my consent to participate in the study described above
and understand that such withdrawal WILL NOT jeopardise any treatment or my
relationship with the St Vincent’s Hospital or my medical attendants.
Signature

Date

Please PRINT Name

The section for Revocation of Consent should be forwarded to Dr Richard Hillman,
IBAC, Xavier Building, St Vincent’s Hospital, Darlinghurst.

APPENDIX FOUR
Ethics Approval St Vincent’s Hospital and University of Wollongong
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APPENDIX FIVE
Questionnaires from Psychosocial Aspects of Screening (Chapter Two)
Psychological Consequences Questionnaire; Positive Scale (PCQ+)
All things considered, would you say your experiences at the Breast X-ray Program
have caused any of the following: 0=Not at all; 1=A little bit; 2= Quite a bit; 3= A great
deal
(E) A sense of reassurance that you do not have breast cancer
(E) Feeling more relaxed
(S) Improved relationship with friends or relations
(P) Feeling more able to do things which you normally do
(P) Feeling more able to meet your home and/or work responsibilities
(E) Feeling more hopeful about the future
(E) Feeling less anxious about breast cancer
(S) Getting on better with those around you
(P) Been sleeping better
(E) A greater sense of well being
N.B.: the positive consequences section is only given to participants after results have
been received.
‘Letters in ‘parentheses’ indicate subscale E = Emotional; P = Physical; S = Social.
Cockburn J, De Luise T, Hurley S, Clover K. Development and validation of the PCQ:
A questionnaire to measure the psychological consequences of screening
mammography. Social Science & Medicine 1992; 34: 1129-1134. doi:10.1016/02779536(92)90286-Y

Knowledge of Anal cancer and HPV questionnaires
What is an anal smear test?
A colposcopy is an investigation for abnormal cells?
An abnormal Pap smear indicates low risk of disease?
A colposcopy examines the anus?
An abnormal smear test result means precancerous changes?
Recommended frequency of an anal Pap smear is 2 years?
Men most likely to have an abnormal test result at age of 40?
Which of the following increase risk of anal cancer?
1. Smoking
2. Being an anal-receptive partner
3. Failure to use condoms
4. High number of sexual partners
5. Other cancers
6. Early age of first sexual intercourse
Have you ever heard of the HPV infection? Yes/No
HPV is
1. Always symptomatic
2. Sometimes symptomatic
3. Never symptomatic
4. Do not know
Which of the following increase the risk of contracting HPV?
1. Early puberty
2. Multiple sexual partners
3. If partner has had multiple sexual partners
4. Early sexual activity
5. Failure to use condoms
HPV is an infection that affects
1. Only or mainly men
2. Only or mainly women
3. Both men and women
4. Do not know
Pitts, M.K., et al., What Do Gay Men Know About Human Papillomavirus? Australian
Gay Men's Knowledge and Experience of Anal Cancer Screening and Human
Papillomavirus. Sexually Transmitted Diseases 2007; 34: 170-173.
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Impact of Events Scale
Below is a list of comments made by people after stressful life events. Please mark
each item, indicating how frequently these comments were true for you during the past
seven days. If they did not occur during that time, please mark the "not at all" column.
Select only one answer per row.
0= Not at all

1= Rarely

3= Sometimes

5= Often

1. I thought about it when I didn't mean to.
2. I avoided letting myself get upset when I thought about it or was reminded about
it.
3. I tried to remove it from memory.
4. I had trouble falling asleep or staying asleep because of pictures or thoughts
about it that came to my mind.
5. I had waves of strong feelings about it.
6. I had dreams about it.
7. I stayed away from reminders about it.
8. I felt as if it hadn't happened or was unreal.
9. I tried not to talk about it.
10. Pictures about it popped into my mind.
11. Other things kept making me think about it.
12. I was aware that I still had a lot of feelings about it, but I didn't deal with them.
13. I tried not to think about it.
14. Any reminder brought back feelings about it.
15. My feelings about it were kind of numb.
Horowitz, M. Wilner, N. & Alvarez, W. Impact of Event Scale: A measure of subjective
stress. Psychosomatic Medicine 1979; 41: 209-218.

Illness Intrusiveness Ratings Scale
The following items ask about how much your illness and/or its treatment interfere with
different aspects of your life. PLEASE CIRCLE THE ONE NUMBER THAT
BEST DESCRIBES YOUR CURRENT LIFE SITUATION.
If an item is not applicable, please circle the number one (1) to indicate that this aspect
of your life is not affected very much. Please do not leave any item unanswered. Use
this scale for each item:
Not Very Much 1 2 3 4 5 6 7 Very Much
How much does your illness and/or its treatment interfere with your:
1. HEALTH
2. DIET (i.e., the things you eat and drink)
3. WORK
4. ACTIVE RECREATION (e.g., sports)
5. PASSIVE RECREATION (e.g., reading, listening to music)
6. FINANCIAL SITUATION
7. RELATIONSHIP WITH YOUR SPOUSE (girlfriend or boyfriend if not married)
8. SEX LIFE
9. FAMILY RELATIONS
10. OTHER SOCIAL RELATIONS
11. SELF-EXPRESSION/SELF-IMPROVEMENT
12. RELIGIOUS EXPRESSION
13. COMMUNITY AND CIVIC INVOLVEMENT
Devins G.M. Using the Illness Intrusiveness Ratings Scale to understand health-related
quality of life in chronic disease. Journal of Psychosomatic Research 2010; 68: 591-602.
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Hospital Anxiety and Depression Scale
Please read each item carefully and circle the answer that says how you have felt in the
last week
I feel tense or wound up
I still enjoy the things I
used to
I get a frightened feeling
as if something awful is
going to happen
I can laugh and see the
funny side of things
Worrying thoughts go
through my mind
I feel cheerful
I can sit at ease and feel
relaxed
I feel as if I am slowed
down
I get a frightened feeling
like butterflies in the
stomach
I have lost interest in my
appearance
I feel restless, as if I have
to be on the move
I look forward with
enjoyment to things
I get sudden feelings of
panic
I can enjoy a good book or
radio or TV programme

Most of the
time
Definitely
Very
definitely &
quite badly
as much as
ever
a great deal
of the time
not at all

a lot of the
time
not quite so
much
yes but not
too badly

time to time,
occasionally
only a little

not at all
hardly at all

not quite so
much
a lot of the
time
not often

a little but it
doesn’t
worry me
definitely not
so much
from time to
time
sometimes

definitely

usually

not often

only
occasionally
most of the
time
not at all

nearly all the
time
not at all

very often

sometimes

not at all

occasionally

quite often

very often

definitely
very much
indeed
as much as I
ever did
Very often
indeed
often

not at all
not at all

I don’t take
I may not
I take as
as much care take so much much care as
as I should
care
ever
quite a lot
not very
not at all
much
rather less
definitely
hardly at all
less
quite often
not often
not at all
sometimes

not often

very seldom

Zigmond, A.S., Snaith, R.P. The hospital anxiety and depression scale. Acta
Psychiatrica Scandinavica 1983; 67: 361-370.

HIV Symptom Index
The following questions ask about symptoms you might have had during the past 4
weeks. Please check the box that described how much you have been bothered by each
symptom.
0= I do not have this symptom; I have this symptom and…1= It doesn’t bother me, 2= It
bothers me a little, 3= It bothers me, 4= It bothers me a lot.
1. Fatigue or loss of energy
2. Fevers, chills or sweat
3. Feeling dizzy or light-headed
4. Pain, numbness or tingling in the hands or feet
5. Trouble remembering
6. Nausea or vomiting
7. Diarrhoea or loose bowel movements
8. Felt sad, down or depressed
9. Felt nervous or anxious
10. Difficulty falling or staying asleep
11. Skin problems, such as rash, dryness or itching
12. Cough or trouble catching your breath
13. Headache
14. Loss of appetite or a change in the taste of food
15. Bloating, pain or gas in your stomach
16. Muscles aches or joint pain
17. Problems with having sex, such as loss of interest or lack of satisfaction
18. Change in the way your body looks such as fat deposits or weight gain
19. Problems with weight loss or wasting
20. Hair loss or changes in the way your hair looks
Justice, A.C., Holmes, W., Gifford, A.L., et al. Development and validation of a selfcompleted HIV symptom index. Journal of Clinical Epidemiology 2001; 54: (SUPPL.
1) S77-S90.
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Depression Anxiety Stress Scale
Please read each statement and circle a number 0, 1, 2 or 3, which indicates how much
the statement applied to you over the past week. There are no right or wrong answers.
Do not spend too much time on any statement.
The rating scale is as follows:
0
Did not apply to me at all
1
Applied to me to some degree, or some of the time.
2
Applied to me to a considerable degree, or a good part of the time.
3
Applied to me very much, or most of the time.
I found it hard to wind down
I was aware of dryness of my mouth
I couldn’t seem to experience any positive feeling at all
I experienced breathing difficulty (e.g., excessively rapid
breathing, breathlessness in the absence of physical exertion)
I found it difficult to work up the initiative to do things
I tended to over-react to situations
I experienced trembling (e.g., in the hands)
I felt that I was using a lot of nervous energy
I was worried about situations in which I might panic and make
a fool of myself
I felt that I had nothing to look forward to
I found myself getting agitated
I found it difficult to relax
I felt down-hearted and blue
I was intolerant of anything that kept me from getting on with
what I was doing
I felt I was close to panic
I was unable to become enthusiastic about anything
I felt I wasn’t worth much as a person
I felt that I was rather touchy
I was aware of the action of my heart in the absence of physical
exertion (e.g., sense of heart rate increase, heart missing a beat)
I felt scared without any good reason
I felt that life was meaningless

0
0
0
0

1
1
1
1

2
2
2
2

3
3
3
3

0
0
0
0
0

1
1
1
1
1

2
2
2
2
2

3
3
3
3
3

0
0
0
0
0

1
1
1
1
1

2
2
2
2
2

3
3
3
3
3

0
0
0
0
0

1
1
1
1
1

2
2
2
2
2

3
3
3
3
3

0
0

1
1

2
2

3
3

Lovibond, P., Lovibond, S. The Structure of Negative Emotional States: Comparison of
the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety
Inventories. Behaviour Research & Therapy 1994; 33: 335-343.

SF-12 Health Survey Form
INSTRUCTIONS: This survey asks for your views about your health. This
information will help keep track of how you feel and how well you are able to do your
usual activities.
Answer every question by marking one box. If you are unsure about how to
answer a question, please give the best answer you can.
1. In general, would you say your health is:
Excellent

Very good

Good

Fair

Poor

The following items are about activities you might do during a typical day. Does your
health now limit you in these activities? If so, how much?
ACTIVITIES

2. Moderate activities, such as moving a table,
pushing a vacuum cleaner, bowling, or playing golf
3. Climbing several flights of stairs

Yes,
Yes,
No,
Limited Limited Not
A Lot
A Little Limited
At All









During the past week, have you had any of the following problems with your work or
other regular daily activities as a result of your physical health?
4. Accomplished less than you would like

YES


NO


5. Were limited in the kind of work or other activities





During the past week, have you had any of the following problems with your work or
other regular daily activities as a result of any emotional problems (such as feeling
depressed or anxious)?
6. Accomplished less than you would like

YES


NO


7. Didn't do work or other activities as carefully as usual
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8. During the past week, how much did pain interfere with your normal work, include
both outside the home and housework?
Not at all

A little bit

Moderately

Quite a bit

Extremely

These questions are about how you feel and how things have been with you during
the past week.
For each question, please give ONE answer that comes closest to the way you have been
feeling. How much of the time during the past week –

9. Have you felt calm and
peaceful?
10. Did you have a lot of
energy?
11. Have you felt
downhearted and blue?

All of
the
time

Most
of the
time


A Good
Bit of
the
time











Some
of the
Time


A
Little
of the
Time


None
of the
Time


















12. During the past week, how much of the time has your physical health or emotional
problems interfered with your social activities, like visiting with friends, relatives, etc.?
All of the time

Most of the
time

Some of the
time

A little of the
time

None of the
time

Andrews G. A brief integer scorer for the SF-12: validity of the brief scorer in
Australian community and clinic settings. Australian and New Zealand Journal of
Public Health 2002; 26: 508-510.

Distress Thermometer
Please circle the number 0-10 that best describes how much distress you experienced:
Time One: Taking the swab
Time Two: Waiting for the swab results
Time Three: During the “HRA” procedure; Waiting for the “HRA” results; Since the
“HRA” Results
Time Three Control Group: In the last week
10
9
8
7
6
5
4
3
2
1
0

Extreme distress

No distress

Jacobsen, P., Donovan, K., Trask, P., Fleishman, S., Zabora, J., Baker, F., Holland, J.
Screening for Psychologic Distress in Ambulatory Cancer Patients. Cancer 2004; 103:
1494-1502.
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Anal Screening Questionnaire
We would like to know how you have been feeling since your anal swab/ anal swab
results/ HRA results this week. Please circle the response which most closely applies to
you.
Since my anal swab I feel:
Since my anal swab results I
feel:
Since my HRA results I feel:
1. In good general health

Better than
usual

Same as
usual

Worse than
usual

Much worse
than usual

2. Happy about the way my
body feels

Better than
usual

Same as
usual

Worse than
usual

Much worse
than usual

3. In control of my body

Better than
usual

Same as
usual

Worse than
usual

Much worse
than usual

4. In good anal health

Better than
usual

Same as
usual

Worse than
usual

Much worse
than usual

5. Optimistic about my
future health

Better than
usual

Same as
usual

Worse than
usual

Much worse
than usual

Not at all

No more
than
usual

Rather more
than usual

Much more
than usual

6. Interested in sex

Wardle J., Pernet A., Stephens D. Psychological Consequences of Positive Results in
Cervical Cancer Screening. Psychology and Health 1994; 10: 185-194.

Cancer Worry Scale
In the past month:
7. How much have you
thought about anal
cancer?
8. How often has the
possibility that you might
develop anal cancer
worried you?
9. How much of the time
have you worried about
dying soon?
10. How reassured about anal
cancer do you feel as a
result of your HRA
results?
11. Has your life changed for
the better, the worse, or
not at all because of your
HRA results?
12. What do you think is
your chance of getting
anal cancer some day?

A lot

Some

Only a little

Not at all

A lot

Some

Only a little

Not at all

A lot

Some

Only a little

Not at all

A lot

Some

Only a little

Not at all

For the better

Much
more
than
average

A little
more
than
average

For the worse

Same as
average

Not at all

A little
less than
average

Much
less than
average

McNaughton-Collins M., Fowler F., Caubet J., Bates D., Lee J., Hauser A., and Barry
M. Psychological effects of a suspicious prostate cancer screening test followed by a
benign biopsy result. The American Journal of Medicine 2004; 117: 719-725.
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